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Macrophages are innate immune cells that protect against pathogens and maintain tissue 
integrity. In vertebrates, macrophages reside in every tissue where they perform specific 
functions from early development through adulthood. While macrophages provide important 
functions across all tissues, a major focus in recent years has been the role of resident brain 
macrophages, known as microglia, in neurodegeneration. As microglia have been shown to 
affect brain development, homeostasis, and disease, they demonstrate how immune cells 
critically mediate neurological health and point to the broader significance of neuroimmune 
interactions, or the coordinated actions of the nervous and immune systems for maintaining 
tissue health. However, the nervous system also includes peripheral nerves, which not only 
enable the brain to communicate with the external environment, but are indispensable for 
maintaining bodily functions. While the peripheral nervous system (PNS) also contains resident 
macrophages, they are much less characterized than brain microglia. For my dissertation, I set 
out to investigate PNS macrophages and compare them with their counterparts in the central 
 xi 
nervous system (CNS). My work began with the identification and transcriptional 
characterization of PNS macrophage across peripheral nerves. I found that self-maintaining PNS 
macrophages were transcriptionally related to CNS microglia and expressed many transcripts 
previously thought to be exclusive to microglia. PNS macrophages also expressed unique 
transcripts reflecting tissue-specific roles and, remarkably, genes previously identified to be 
upregulated by activated microglia during aging, neurodegeneration, or loss of Sall1. I next 
examined the developmental features of PNS macrophages and found that they rely on IL-34 for 
maintenance and arise from both embryonic and hematopoietic precursors. The majority of 
transcriptional signatures in PNS macrophages did not differ by ontogeny, suggesting that nerve 
environment specifies PNS macrophage identity at steady state. Finally, my work reveals the 
responsiveness of PNS macrophages to changes in nerve environment. PNS macrophages shifted 
their gene expression to become more microglia-like in a dysmyelination model. After injury, 
PNS macrophages strikingly expressed a set lipid-handling genes that resembled “foamy” 
macrophages. Targeting of lipid metabolism by high fat diet improved nerve regeneration in a 
manner suggesting partial dependence on PNS macrophages. Collectively, these findings 
uncover shared and unique features between neural resident macrophages, emphasize the role of 
nerve environment for shaping PNS macrophage identity, and point to the therapeutic potential 




1. Introduction  
1.1 Macrophages in host defense and tissue homeostasis 
The discovery of macrophages stems back to studies in the late nineteenth century by Ilya 
Metchnikoff 1. In his seminal observation, he saw that motile cells in starfish larvae, which he 
believed were important for the animals’ immune defenses, congregated around rose thorns that 
were inserted into their bodies. These cells, which he also found in vertebrates, were called 
“phagocytes” because of their ability to take up particulate matter. Experiments from 
Metchnikoff and others revealed that phagocytosis is an important process that protects the body 
from foreign invaders 2. This finding serves as a foundational principle for the field of 
immunology. 
In mammals, macrophages are organized in defined patterns across all tissues and their 
components, with each cell occupying its own microanatomical domain 3. This integration of 
macrophages into tissues positions them as a first line of defense against invading pathogens. 
Evidence for this concept in humans became apparent during the first half of the twentieth 
century as research in pathology and immunology turned to the role of macrophages in 
pulmonary tuberculosis 2. While it was known at the time that Mycobacterium tuberculosis (M. 
tuberculosis) could survive and replicate in macrophages, it was unclear how macrophages 
influenced infection. A culmination of work from notable scientists, including Florence Sabin 
and Max Lurie, suggested that macrophages and monocytes, phagocytic leukocytes in blood that 
can differentiate into tissue macrophages, were central players in the control of M. tuberculosis 2. 
This concept was further expanded by George Mackaness, who observed in the 1960s that 
macrophage phagocytosis of bacteria could be increased by factors from sensitized T 
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lymphocytes, a process that he termed macrophage “activation” 4. These early studies would lead 
to extensive research detailing the roles of macrophages in immunity.  
Indeed, the current understanding of innate and adaptive immunity, which refer to the 
more primitive immune system found in metazoans and the acquired immune system found in 
vertebrates, respectively, can be significantly attributed to the study of macrophages. As 
professional phagocytes that broadly recognize and destroy infectious agents via pattern 
recognition receptors (PRRs) that bind to microbes, macrophages are recognized as key players 
in innate immunity 5. However, macrophages also coordinate adaptive immune functions that 
arise when innate immune responses are insufficient to control infection. Adaptive immune 
responses are dependent on the activation of T cells by specialized antigen presenting cells 
(APCs), such as dendritic cells (DCs) and macrophages, which capture foreign material, known 
as antigen, and present them on MHC molecules to naïve T cells 6. In response to antigen 
presentation and co-stimulation by MHC-II+ APCs, CD4+ T cells differentiate into helper T (Th) 
cells, which clonally expand and secrete cytokines that target specific pathogens, in part by 
activating macrophage responses 7. Follicular Th cells in secondary lymphoid organs also 
facilitate the production of highly specific antibodies from B cells, which can bind to pathogens 
and further enhance their uptake by macrophages 8. Thus, the capability to present antigens, 
enhance the antigen presentation process via inflammatory mediators, and respond to effector 
mechanisms by lymphocytes places macrophages in a key position to coordinate both innate and 
adaptive immunity.  
The ability of macrophages to interpret microenvironmental changes and actuate tissue 
responses is not just important for orchestrating effective immune responses; it is also critical for 
proper tissue development and homeostasis. For instance, in mice with genetic deletion of colony 
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stimulating factor 1 (CSF1), a survival factor for macrophages that signals through the colony 
stimulating factor 1 receptor (CSF1R), there is severe osteopetrosis due to the absence of bone 
macrophages or osteoclasts, which normally function to facilitate bone remodeling 9. The 
absence of macrophages in these mice is also associated with abnormal vascular patterning and 
altered brain development 10. Remodeling deficiencies in CSF1 null mice have also been 
observed in other tissues, including the mammary gland, kidney and pancreas 11. These findings 
suggest a general requirement for macrophages in tissue development and remodeling.  
In both development and homeostasis, macrophages phagocytose apoptotic cells that 
have undergone programmed cell death. This process, also known as efferocytosis, prunes down 
apoptotic cells and is necessary to dispose of short-lived or underdeveloped cells 12. Evidence 
from mouse models and patients with systemic lupus erythematosus (SLE) indicate that failure to 
engulf and degrade dead cells and debris can cause widespread inflammation and autoimmune 
disease affecting the skin, kidney, lungs, blood vessels, and nervous system 13. Of note, the 
phagocytosis of apoptotic cells in homeostatic conditions does not result in inflammatory 
cytokine production by macrophages. Rather, macrophage uptake of dying cells has been shown 
to suppress inflammation and auto-immunity in response to self-antigens that might arise during 
homeostasis 14. 
Macrophages also play important roles in lipid metabolism and inflammatory disease. In 
obesity, adipose tissue macrophages are significantly expanded due to Ly6C+ monocyte 
recruitment and differentiation into macrophages 3. The production of inflammatory cytokines, 
such as TNFα, IL-6, and IL-1β, by these cells contribute to low-grade inflammation and insulin 
resistance 3,15. The inflammatory role of macrophages is also well known in atherosclerosis. In 
atherosclerotic plaques, oxidized LDL is taken up by macrophages via scavenger receptors, 
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which leads to high intracellular levels of cholesterol and the “foamy” appearance of such 
macrophages 16. While recent work by our group has shown that the production of inflammatory 
cytokines comes from non-foamy macrophages in atherosclerotic plaques 17, the role of 
inflammation in disease progression remains undisputed 16. Importantly, the regulation of 
inflammation in macrophages is closely linked to their own lipid metabolism 18. Indeed, this 
feature has important implications across all studies of inflammatory disease. 
 
1.2 Characterization of macrophages: historical and modern 
approaches  
The enormous progress in macrophage research over the past century cannot be separated 
from the development of new scientific tools and technologies. Since the early investigations of 
macrophages using dyes to stain and distinguish them as mononuclear phagocytes, there have 
been numerous key techniques that have enabled breakthroughs in macrophage characterization.  
As systematic assessments of tissues indicated that macrophages were present in different 
organs, including liver, brain, lungs, and bone, researchers began to investigate their origins. By 
the 1930s, evidence existed that blood monocytes could give rise to tissue macrophages, usually 
after pathological insult 2. In 1965,Volkman and Gowans confirmed using radioactive tracing 
and parabiosis, a technique which surgically joins the circulatory systems of two living 
organisms, that macrophage precursors could arise from bone marrow during inflammation 19. 
This led to the popular belief that macrophages arose from blood-circulating monocytes, which 
themselves came from progenitors in the adult bone marrow 20. In 1969, Van Furth and 
colleagues proposed the “mononuclear phagocyte system” (MPS) to classify promonocytes and 
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their precursors in the bone marrow, monocytes in the peripheral blood, and macrophages in 
tissues 2. While the MPS classification is still used today, we now know that tissue resident 
macrophages are mostly maintained independently of bone marrow and rely almost exclusively 
on self-renewal 20, 21. Furthermore, it has been revealed that most tissue-resident macrophages 
arise from embryonic sources during development 22. These studies provide a basis for 
understanding ontogeny within the MPS. 
The more widespread use of immunohistochemistry (IHC), confocal imaging, and flow 
cytometry in the 1980s brought on further advancements in macrophage characterization, 
including the identification of macrophage “specific” markers such as F4/80, Mac1 (CD11b), 
and ED1 (CD68) that could be observed and quantified in cells of interest 23-25. Around the same 
time, evidence emerged to indicate that certain cytokines derived from CD4+ helper T cells 
could promote differential activation states in macrophages. Specifically, it was shown that Th1 
cytokines, such as IFNγ, could polarize macrophages towards a pro-inflammatory or “classical” 
phenotype, while Th2 cytokines, such as IL-4, polarized macrophages towards an anti-
inflammatory or “alternative” phenotype 26-29. These findings and techniques set the stage for 
modern macrophage phenotyping and demonstrated the programmable specialization of 
macrophage responses.  
A more recent approach in the past two decades for characterizing macrophages is 
transcriptional profiling 30. By providing a snapshot of the transcriptome, or sum of all RNA 
transcripts, in samples of interest, this approach has revolutionized the understanding of what 
constitutes a particular cell type through the quantitative assessment of genes that are expressed 
30. Thanks to key efforts contributed by the Immunologic Genome Project (ImmGen), a 
collaborative consortium of immunology and computational biology laboratories, a thorough 
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dissection of gene expression and its regulation in the immune system of the mouse has been 
made publicly available 31. Importantly, transcriptional profiling of resident macrophages by 
ImmGen reveals that macrophages show great transcriptional diversity, reflecting many unique 
classes with distinct “identities” and specialized functions across tissues 31. As even more recent 
technologies in single cell RNA sequencing (SC RNA-seq), epigenomic analysis, and various 
types of high-throughput screening are now available, there is new opportunity for uncovering 
insights into macrophage heterogeneity and function.  
 
1.3 CNS microglia: key players in neuroimmunology  
First identified through cell staining techniques at the beginning of the twentieth century, 
microglia were later revealed by Rio-Hortega in 1919 to be phagocytic cells in the brain 32. 
While the name microglia comes from their belonging to a group of specialized neural support 
cells called “glia” (meaning glue), they are indeed macrophages with critical roles in immunity 
and tissue homeostasis 2.  
Microglia were initially observed in connection to human pathology by neurologists 
examining neurotropic viral infections such as rabies 33, and later in neurodegenerative diseases, 
including Alzheimer’s disease (AD) 34 and multiple sclerosis (MS) 35. Since then, microglia have 
been characterized as the resident macrophages and primary innate immune effector cells in the 
CNS parenchyma 36. Microglia are yolk sac-derived cells that arise during embryogenesis and 
play crucial roles in brain development by regulating neuron survival, neurite process outgrowth, 
synaptic pruning, hypothalamic-pituitary axis formation, and brain vascularization 36. Their own 
development has been shown to be partially dependent on interleukin 34 (IL-34), an alternative 
ligand to CSF1 that also signals through CSF1R 37. Under homeostatic conditions, microglia are 
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ramified cells that sample surrounding tissues for ionic balance, damaged cells, or infectious 
agents 38. In pathologic conditions, however, microglia rapidly become ameboid and respond 
locally to injury signals 39. Microglia function to control neuronal infection and have been shown 
to regulate inflammation in a variety of CNS injury and disease contexts 40, 41.  
In recent years, there has been growing interest in the role of microglia in neurological 
disease. Initial observations confirmed the importance of microglia in humans when monogenic 
disease patients with mutations in CSF1R were found to have major morphological alterations in 
brain structure and severe neurological symptoms 42. Further evidence for the role of microglia in 
pathogenesis were revealed by studies showing that sequence variations in TREM2 and 
TYROBP, which are highly enriched in microglia and also expressed on other myeloid cells, 
results in a recessive chronic neurodegenerative disease characterized by early-onset progressive 
dementia and bone cysts 43,44. Another microgliopathy with neurological symptoms is observed 
in both mouse mutants as well as patients lacking the negative type I interferon receptor 
regulating protease USP18 in microglia 45,46. Furthermore, a potential role for somatic mutations 
in fetal macrophage precursors, including those that give rise to microglia, was linked to CNS 
histiocytoses and late-onset neurodegeneration in mice 47. 
Given the evident role of microglia in nervous system disorders, it is no surprise that they 
have been a focal point in the recent rise of interest in neuroimmunology, which focuses on the 
interplay between the nervous and immune systems in development, health, and disease. Indeed, 
the enormous growth in knowledge of microglia in the past decade, driven in large part by 
advancements in transcriptomics, has significantly shaped how we view the nervous and immune 
systems. One key finding was that microglia have distinct transcriptional signatures compared to 
other tissue-resident macrophages 48. These signatures are strongly dependent on TGF-β1, a 
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molecule that regulates basal microglia phenotype through TGFBR1 and TGFBR2 49. In mice, 
loss of TGF-β signaling in microglia has been shown to cause microgliosis and fatal 
demyelinating disorder 50. These studies imply that factors in the nerve environment are critical 
for maintaining microglial homeostasis. Single cell transcriptomic studies further showed that 
developmental microglia as well as activated microglia in neurodegenerative contexts 
downregulate homeostatic signatures and upregulate disease-associated genes 51,52. These 
observations have sparked great interest in the regulation of homeostatic and activation-
associated genes in microglia and their relevance for development, neuroinflammation, and 
disease susceptibility 52. Targeting microglia to improve or prevent CNS diseases is a current 
topic of intense and exciting study. 
 
1.4 PNS macrophages: a new frontier in neuroimmunology 
In addition to the CNS, the nervous system also includes the peripheral nervous system 
(PNS), which represents the part of the nervous system that is outside of the brain and spinal 
cord. The PNS enables direct communication between the CNS and peripheral tissues and is 
therefore required for the body’s ability to: 1) sense and respond to external stimuli through 
sensory and motor nerves; and 2) maintain homeostatic processes, including cardiovascular, 
immune, endocrine, digestive, and respiratory system regulation via autonomic nerves 53,54.  
While the peripheral nervous system (PNS) also contains resident macrophages, they are 
much less characterized than brain microglia. Indeed, most existing research on PNS 
macrophages is based on histological studies following nerve injury. Early mouse studies of PNS 
macrophages dating back to observations by Olsson and Sjostrand in 1969 demonstrated that 
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after peripheral nerves are crushed, macrophages rapidly invade the site of trauma and the distal 
part of the nerve which undergoes Wallerian degeneration 55-57. It was also noted at the time that 
activated macrophages in nerve injury appeared “foamy” likely as a result of phagocytosing 
myelin 58,59. Besides clearing myelin, it was also suggested that peripheral nerve macrophages 
signal to Schwann cells and fibroblasts, and induced nerve growth 59. Remarkably, many of these 
PNS macrophage functions have been shown decades later with modern techniques 60-62. 
As it became clear that there existed both hematogenous macrophages that arise after 
injury and an endogenous macrophage compartment in normal nerves, attempts were made to 
determine their differential contributions after injury 63. However, the limitation of precise 
lineage tracing tools has prevented accurate characterization of macrophage origins until recent 
years. Nevertheless, it was suggested in 1992 by Monaco and colleagues that resident 
endoneurial macrophages in the PNS were “microglial-like cells” that could act as the major 
antigen-presenting cells in the peripheral nerve given their constitutive MHC-II expression 59.  
Despite the inherent similarity of PNS macrophages to CNS microglia by virtue of 
residing within the nervous system, little is known about their function or identity. Indeed, at the 
beginning of this dissertation work, there was no existing transcriptional profile of PNS 
macrophages. Key reasons for this may be the technical barrier of isolating PNS macrophages as 
well as prohibitive costs for transcriptomic sequencing. However, recent advancements in 
sequencing technologies have enabled much better sequencing of small samples at a much lower 
cost. It is at this point that my research begins. In the subsequent chapters, I describe my work to 
investigate PNS macrophages and compare them with their counterparts in the central nervous 
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The significant role of resident neural macrophages in neuroinflammation and disease 
progression is increasingly appreciated in mouse models and individuals with neurodegeneration 
1-3. Such advances, which largely rely on the interpretation of data from transcriptional analyses 
and human genome-wide association studies of Alzheimer’s disease (AD) and other 
neurodegenerative conditions, have led to critical findings about cellular and molecular processes 
underlying such diseases 4-6. Most of these studies, however, have focused on resident 
macrophages in the brain (microglia) and, to a lesser extent, the spinal cord. Meanwhile, the 
transcriptional identity and functions of resident macrophages in the peripheral nervous system 
(PNS) remain mostly unknown. 
The PNS consists of a multitude of neuronal networks that relay motor and sensory 
information between the central nervous system (CNS) and the rest of the body 7. Although it has 
the capacity to regenerate, the PNS is also prone to injury and degeneration8. Studies of PNS 
injury have shown that PNS macrophages play important roles for debris clearance, pain 
development, and regeneration 9-11. While the contribution of recruited monocytes cannot be 
excluded, these studies demonstrate the importance of PNS macrophages in nerve injury. 
Understanding the roles of these cells in homeostasis and disease may be broadly beneficial for 
resolving neuroinflammation. 
In addition to monocyte-derived macrophages in nerve injury, there are also resident 
macrophages in the PNS at steady state 12,13 . While their residence in neuronal tissues is 
inherently microglia-like, PNS macrophages exist within a unique peripheral nerve 
microenvironment. Here we show that self-maintaining PNS-resident macrophages are a distinct 
population with transcriptional signatures relating to specific functions in neuronal tissue. PNS 
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macrophages significantly express genes that resemble not only homeostatic microglia but also 
activated microglia from aging and neurodegenerative conditions. These findings highlight 
shared and unique transcriptional programs in neural resident macrophages.  
 
2.2 Results 
2.2.1 PNS macrophages are self-maintained resident cells 
To examine resident macrophages in the PNS, we imaged a variety of nerve types at 
steady state using CX3CR1GFP/+ reporter mice. In these mice, green fluorescent protein (GFP) 
effectively labels microglia and has been shown to label nerve-associated macrophages in 
adipose, skin, lung, and enteric tissues 14-18. CX3CR1GFP/+ cells in peripheral nerves were 
ramified with elongated cytoplasmic processes and appeared to be in direct contact with blood 
vessels, Schwann cells, and endoneurial fibroblasts (Fig. 1). CX3CR1GFP/+ cells were found in 
dorsal root ganglia (DRG), vagal nerves (VNs), cutaneous intercostal fascial nerves (FNs), and 
sciatic nerves (SNs) (Fig. 2a). CX3CR1GFP/+ cells were located in the endoneurium (Fig. 2b) 
and expressed CSF1R, also known as CD115 (Fig. 2c). As expected, these cells were susceptible 
to CSF1R signaling blockade, as administration of a monoclonal antibody to CSF1R effectively 
depleted them in nerves (Fig. 3). Using flow cytometry, we found that CX3CR1GFP/+ cells also 
expressed the common macrophage marker CD64 (FcγR1) 19 and intermediate levels of CD45 
(Fig. 2d–f). Thus, CX3CR1GFP/+ cells in peripheral nerves are indeed macrophages with 
resemblance to CNS microglia based on both endoneurial localization and surface marker 
expression 
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To determine whether PNS macrophages depend on circulating precursors or are 
maintained via local signals, we performed parabiosis in CD45.1+ wild type and CD45.2+ 
Lyz2Cre × tdTomatofl/fl mice, and assessed the extent to which cells circulating from the 
parabiotic partner gave rise to PNS macrophages. Ten weeks after joining the parabionts, we 
found minimal exchange of PNS macrophages in all of the nerve types examined, whereas blood 
T cells and monocytes exchanged robustly (Fig. 2g and Fig. 4). Indeed, most of the tdTomato+ 
cells that could be seen in the wild-type parabiont were localized to the tissue surrounding the 
nerves (Fig. 2h). We also performed pulse-chase labeling of PNS macrophages using tamoxifen-
inducible CSF1RMer-iCre-Mer × tdTomatofl/fl mice. In these mice, tdTomato expression 
persists in self-maintaining cells, but not in monocytes, which mostly turn over by 3–4 weeks 
after tamoxifen removal 20,21. Heterozygous mice were fed tamoxifen diet for 4 weeks and then 
switched to normal diet (Fig. 2i). Just following tamoxifen removal, 96% of PNS macrophages 
(pooled from all PNS sites), 99% of CNS microglia, and 100% of blood monocytes were 
tdTomato+ (Fig. 2j–l and Fig. 5). Whereas only 20% of nonclassical and classical monocytes 
were still tdTomato+ by 3 weeks after tamoxifen removal, 98% of CNS microglia and 95% of 
pooled PNS macrophages remained labeled up to 8 weeks following tamoxifen removal (Fig. 1l 
and Supplementary Fig. 2). Taken together, these results indicate that PNS macrophages are 
mostly self-maintained in adult mice. 
 
2.2.2 Transcriptional characterization of PNS macrophages 
As we and others have previously demonstrated, unique gene expression profiles can be 
obtained in tissue-resident macrophage populations across tissue types 19,22. To identify signature 
genes in peripheral nerve macrophages, we performed bulk RNA sequencing (RNA-seq) to 
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compare purified PNS resident macrophages sorted from DRG, VN, cutaneous intercostal FN, 
and SNs (Fig. 6) with CNS microglia from the brain and spinal cord, as well as previously 
characterized conventional macrophage populations from the spleen, peritoneal cavity, and 
lungs. Global transcriptomic analysis revealed similarities within resident neural macrophages 
from both PNS and CNS, with PNS macrophages clustering more closely to CNS microglia than 
to conventional macrophages (Fig. 7a). A substantial number of genes were uniquely enriched in 
PNS macrophages and CNS microglia compared with the other tissue-resident macrophages, 
including microglial signature genes Tmem119, P2ry12, Siglech, Trem2, and Olfml3 (Fig. 7b, c). 
PNS macrophage-specific genes were also identified (Fig. 7b). 
To determine potential functions of PNS macrophages associated with their shared and 
unique gene expression profiles, we performed Gene Ontology analysis on transcripts that were 
common between PNS macrophages and CNS microglia, and those that were specific to PNS 
macrophages. Consistent with the idea that PNS macrophages may share functions with CNS 
microglia, pathway analysis identified functions including synaptic plasticity, microglial 
motility, and positive regulation of neurogenesis (Fig. 7d). Pathways that were unique to PNS 
macrophages included angiogenesis, collagen fibril organization, regulation of BMP signaling, 
and peripheral nerve structural organization and axon guidance (Fig. 7e). 
Next, we identified transcripts that were 4-fold or more enriched in CNS microglia and 
PNS macrophages relative to their expression in all other conventional macrophage populations 
(Fig. 7f). These upregulated genes included Abhd6, Ophn1, P2rx7, Pld1, Sgce, Tgfbr1, Tfpi, 
and Tmem173. We also identified several genes that were downregulated in CNS microglia and 
PNS macrophages (Fig. 8). Notably, the transcriptional regulator that defines microglial identity 
and function, Sall1, was not expressed by PNS macrophages (Fig. 7c). Modest detection 
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of Sall1 in the DRG could not be corroborated by further analysis (Fig. 9). This may reflect 
unique adaptations in PNS and CNS macrophages. Indeed, we identified 72 genes, 
including Sall1, which were highly specific to CNS microglia (Fig. 10). 
To examine unique gene expression in PNS macrophages, we identified transcripts that 
were at least fourfold higher or lower in PNS macrophages compared with other resident 
macrophages, including CNS microglia (Fig. 7g and Fig. 11). We found 48 genes specifically 
enriched in PNS macrophages, including Aplnr, Cp, Il1rl1, Maoa, Pla2g2d, and St8sia4, as well 
as interferon-induced genes Ifi202b, Ifi211, and Oas2. We also identified Ms4a14, Ms4a4a, 
Ms4a4c, Ms4a6c, and Ms4a7. These signatures reveal unique transcriptional programming in 
PNS macrophages and may provide clues about their involvement in neuronal health and disease. 
We next investigated transcriptional differences within PNS macrophage populations 
(Fig. 12). Using a fourfold cutoff, we identified 24 genes enriched in SN macrophages, 23 genes 
enriched in cutaneous intercostal (fascial) nerve macrophages, and 12 genes enriched in VN 
macrophages. We observed similar numbers of downregulated genes in each population. We also 
compared nerve-resident macrophages to those residing within the dorsal root ganglion and 
found that they were significantly different, with many differentially expressed transcripts. 
Therefore, we re-analyzed this data using a more stringent 8-fold cutoff and identified 79 
upregulated genes and 52 downregulated genes. These results suggest that although PNS 
macrophages are transcriptionally similar, significant differences exist between those adjacent to 
axons and those residing close to neuronal cell bodies. 
 
2.2.3 PNS macrophages constitutively express transcripts associated with 
activated microglia 
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To investigate differentially expressed genes (DEGs) within resident neural macrophages, 
we refined our analysis to CNS microglia and PNS macrophages (Fig. 13a). We identified 396 
genes enriched in PNS macrophages and 180 genes enriched in CNS microglia. As the 
upregulation of MS4A family and interferon-induced genes has been reported to characterize 
aged and neurodegenerative disease-associated microglia 6,23,24, we wondered whether PNS 
macrophages expressed other genes associated with microglial activation. By cross-referencing 
published data 6, we determined the number of connections between disease-associated genes 
that were upregulated in activated microglia from aging, phagocytic, and neurodegenerative 
conditions and neural macrophage-enriched genes from either PNS macrophages or CNS 
microglia (Fig. 13b). We found 148 disease-associated genes that were enriched in PNS 
macrophages compared to 17 that were enriched in CNS microglia (Fig. 13b). From the highest 
connectivity groups 6–4, we identified 25 genes that were significantly higher in PNS 
macrophages, including Ch25h, Anxa2, Cd52, Ifitm3, Cybb, Fxyd5, Igf1, and Apoe(Fig. 13c). 
Microglia lacking certain genes for homeostatic regulation have also been found to shift 
their gene expression towards an activated phenotype 25,26. Sall1 has been identified as a 
transcriptional regulator of microglia identity and function, with Sall1−/− microglia resembling 
inflammatory phagocytes 25. As PNS macrophages did not express Sall1at steady state, we 
examined whether genes that are reportedly dysregulated in Sall1−/− microglia showed the same 
pattern of expression in PNS macrophages. Indeed, we found a high correlation between genes 
enriched in PNS macrophages and Sall1−/− microglia, including Apoe, H2-
Aa, Ms4a7, Clec12a, Aoah, and Cybb (Fig. 13d). These data suggest that, beyond the difference 
in Sall1-driven gene expression, PNS macrophages may share common genetic regulators with 
CNS microglia. 
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As microglia activation may occur under cell sorting conditions 27, we were concerned 
that the activation signature in PNS macrophages might be attributed to tissue preparation. Thus, 
we stained freshly fixed peripheral nerves for Clec7a and MHCII, which are induced in 
microglia across many activation states 6,26,28. Resting PNS macrophages were clearly marked by 
Clec7a and MHCII (Fig. 13e), suggesting that the signature obtained in PNS macrophages is not 
a technical artifact that arose from activation induced by disaggregation of tissue. Since 
microglial activation signatures have been associated with phagocytosis of nerve material 6, we 
speculated that PNS macrophages may be more phagocytic compared to microglia. To test this, 
we assessed fluorescent bead uptake in microglia and sciatic nerve macrophages. Indeed, we saw 
that a higher proportion of sciatic nerve macrophages (23%) engulfed beads compared to brain 
microglia (0.2%) (Fig. 14).  Taken together, these data show that PNS macrophages not only 
express a wide array of microglial activation genes at steady state, but also appear to be more 
phagocytic than CNS microglia.  
 
2.2.4 Zonation of PNS macrophage-enriched transcripts in neural resident 
macrophages  
Given the difference in gene expression between PNS macrophages and CNS microglia, 
we wanted to further discriminate the influence of microenvironment on neural macrophage 
identity. Thus, we examined spinal cord microglia, which reside in a distinct microenvironment 
from brain microglia. Interestingly, we found a set of genes that were high in PNS macrophages, 
intermediate to high in spinal cord microglia and low in brain microglia (PNS to CNS zonation) 
(Fig. 15a). These included PNS macrophage-specific genes (Cp, Il1rl1, Maoa, and Cdr2), 
microglial activation genes (Clec7a, Spp1, Lpl, Axl, Ms4a4c, and Ms4a6c), interferon-induced 
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genes (Ifi204, Ifi207, Ifi209, and Oasl2), mitochondrially encoded genes (mt-Nd1, mt-Nd2, mt-
Nd4, mt-Nd5, and mt-Nd6), and several transcription factors (Hivep2, Zfp704, and Rbpj) (Fig. 
15b, c). While we confirmed Clec7a expression in spinal cord microglia by immunostaining (Fig. 
15c), Clec7a+ microglia appeared to be confined to areas of white matter, suggesting that 
activation-associated genes in spinal cord microglia may be specific to myelinated regions (Fig. 
16). Importantly, microglia from spinal cord and brain did not significantly differ by expression 
of homeostatic genes Sall1, Olfml3, and Tmem119 (Fig. 17). In fact, certain microglial genes, 
including Tgfbr1 and P2ry12, were more highly expressed in spinal cord compared with brain 
microglia. These findings suggest that transcriptional programs underlying PNS macrophages 
and activated microglia may be present during normal physiological conditions and further 
support the role of nerve environment for specifying neural macrophage identity. 
 
2.3 Discussion 
Here we characterized the transcriptomes of PNS resident macrophages across various 
nerve types spanning both axons and cell bodies and innervating a wide range of somatic targets. 
We show that self-maintaining PNS macrophages lack expression of the master regulator Sall1 
conferring CNS microglial identity, but nonetheless express a substantial number of genes that 
define homeostatic and activated microglia. 
Our findings demonstrating that PNS macrophages share a significant overlap in gene 
expression with CNS microglia are in line with recent findings that show microglial genes being 
expressed in nerve-associated macrophages in gut, skin, and adipose tissues 14-17. Given that our 
study focuses on PNS macrophages residing in the nerve proper whereas these studies examined 
macrophages positioned in close proximity to nerves, including nerve termini, it seems likely 
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that common tissue-derived factors may induce nerve-imprinted signatures in macrophages along 
the entire neuron. One such factor may be transforming growth factor-β (TGF-β). TGF-β 
signaling is vital for the expression of homeostatic genes in microglia 2,5. The higher expression 
of Tgfbr1 in PNS macrophages and CNS microglia at steady state supports the role of TGF-β 
signaling in neural resident macrophages.  
Although common instructive signals may exist, Sall1 expression was very low to absent 
in PNS macrophages. This likely represents a key difference in PNS and CNS nerve 
environments. The identification of additional genes that were purely expressed in CNS 
microglia may provide clues for the basis of this difference. Future studies should address 
genetic and environmental factors that regulate Sall1expression and examine whether it is 
expressed in a context-dependent manner in PNS macrophages. 
The constitutive expression of a broad set of microglial activation genes in PNS 
macrophages and, to a lesser degree, in spinal cord microglia suggests that such programs may 
be intrinsic to their functioning in distinct neuronal environments. Indeed, it was found that 
sympathetic nerve-associated macrophages and macrophages at CNS interfaces also appear to be 
constitutively activated 14,29,30. In addition, an overlap in many of the same activation genes are 
induced in phagocytic microglia localized to white matter tracts during brain development 31. In 
addition to their role in phagocytic functions, activation-associated genes may also play a role in 
pathogen response. This is supported by the recent finding that nerve-associated macrophages 
residing in lungs readily respond to viral infection 18. Further studies are needed to determine 
whether immune response to pathogens or phagocytic and tissue remodeling programs are more 
prevalent at steady state in PNS macrophages. 
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2.4 Materials and methods 
Experimental animals 
Mouse care and experiments were performed in accordance with protocols approved by 
the Institutional Animal Care and Use Committee at Washington University in St. Louis under 
the protocols 20170154 and 20170030. Mice were kept on a 12 h light–dark cycle and received 
food and water ad libitum. The following strains were used: C57/B6 CD45.1 (stock number 
002014), CX3CR1GFP/+(Cx3cr1tm1Litt/LittJ; stock number 008451), LysMcre/+ (stock number 
004781), and RosaLsl-Tomato (stock number 007905) mice were purchased from Jackson 
Laboratory (JAX) and bred at Washington University. CSF1RMer-iCre-Mer mice 32 were obtained 
from JAX (stock number 019098) and backcrossed fully to C57BL/6 background using the speed 
congenics core facility at Washington University. MPZ-Cre mice, previously described 33, were 
crossed with CX3CR1GFP/+ mice. Sall1-GFPmice 25,34 were kindly provided by M. Rauchman. 
 
Immunohistochemistry 
For whole-mount imaging, samples were harvested and immediately stored in 4% 
paraformaldehyde (PFA) containing 40% sucrose overnight. Samples were then washed in 
phosphate-buffered saline (PBS), blocked, stained, and imaged. For frozen sections, samples 
were collected, stored in PFA/sucrose, and embedded into optimal cutting 
temperature compound. Fifteen-micrometer cuts were made for SNs. Sections were then blocked 
in 1% bovine serum albumin, stained, and imaged. Antibodies to the following proteins were 
used: anti-GFP, Clec7a (Clone R1-8g7), CSF1R (R&D Systems, accession number P09581), 
MHCII (IA/IE clone M5/114.15.2), and LYVE1 (ab14917). 
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Preparation of single-cell suspensions 
For blood, mice were bled from the cheek immediately before killing and cells were 
prepared as previously described. For nerves and all other tissues, mice were killed and perfused 
with PBS. Nerves were collected and kept on ice until dissociation. For ImmGen samples, nerves 
from 4 to 20 mice were pooled for each replicate. Cells were then incubated with gentle shaking 
for 20 min in digestion media containing collagenase IV, hyaluronidase, and DNAse. Cells were 
then washed and filtered through 70 µm cell strainers. For brain and spinal cord, myelin was 
removed using a 40/80% Percoll gradient. 
 
Flow cytometry 
Single-cell suspensions were stained at 4 °C. Dead cells were excluded by propidium 
idodide (PI). Antibodies to the following proteins were used: B220 (clone RA3-6B2), CCR2 
(clone SA203G11), CD3e (clone 145-2C11), CD4 (clone RM4-5), CD8 (clone 53-6.7), CD11b 
(clone M1/70), CD16 (clone 2.4G2), CD45 (clone 30-F11), CD64 (clone X54-5/7.1), CD115 
(clone AFS98), GR1 (clone 1A8), and Ly6C (clone HK1.4). Cells were analyzed on a LSRII 
flow cytometer (Becton Dickinson) and analyzed with FlowJo software. 
 
Cell sorting 
For bulk RNA-seq, cells from 6-week-old male mice were double sorted on a FACSAria 
II (Becton Dickinson) for a final count of 1000 cells into lysis buffer according to the ImmGen 
Consortium standard operating protocol. Tissues were collected into culture medium on ice and 
subsequently digested with collagenase IV, hyaluronidase, and DNAse. Following digestion, 
samples were washed and kept on ice until sorting. The sort was repeated so that all 
 27 
macrophages were sorted twice, with a minimum of 1000 cells recovered. During the second 
round, cells were sorted directly into 5 µl TCL buffer (Qiagen) containing 5% beta-
mercaptoethanol. Samples were kept at −80 °C until further processing.  
 
Parabiosis 
Parabiotic pairs were generated as previously described 35. C57/B6 (CD45.1) mice were 
paired with Lyz2Cre tdTomato (CD45.2) mice. Mice were injected with buprenorphine-SR 
subcutaneously prior to surgery. After 10 weeks, mice were killed and nerve tissue was 
examined by flow cytometry and imaging to detect hematopoietic contribution to PNS resident 
macrophages. T cells in blood was used as a positive control. 
 
Antibody depletion 
Adult mice were injected intraperitoneally (i.p.) with anti-CSF1R monoclonal antibody 
(mAb) at a concentration of 2mg per animal. 10 days later, mice were sacrificed for imaging and 
flow cytometric analysis. 
 
Pulse chase 
Male and female heterozygous CSF1RMer-iCre-Mer tdTomato were fed tamoxifen diet for 4 
weeks to label resident cells. Blood was collected at day 0, 3 weeks, 4 weeks, and 8 weeks after 
tamoxifen removal. Peripheral nerves from SNs, FNs, VNs, and DRG were pooled (PNS) and 
examined along with pooled brain and spinal cord (CNS) by flow cytometry at day 0 and 8 
weeks following tamoxifen removal. 
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Bead uptake assay 
Brains and sciatic nerve tissues were collected from CX3CR1GFP/+ mice and minced. 
Tissues were then digested with Collagenase IV for 30 minutes at 37 degrees Celsius, during 
which time the same amount of red fluorescent latex beads were added to brain and sciatic nerve 
homogenates. Samples were then prepared normally for flow cytometry as previously described .  
 
RNA-seq and data analyses 
     Library preparation, RNA-seq, data generation and quality-control was conducted by the 
ImmGen Consortium according to the consortium’s standard protocols 
(https://www.immgen.org/Protocols/ImmGenULI_RNAseq_methods.pdf). In short, the reads 
were aligned to the mouse genome GRCm38/mm10 primary assembly and gene annotation 
vM16 using STAR 2.5.4a. The raw counts were generated by using featureCounts 
(http://subread.sourceforge.net/). Normalization was performed using the DESeq2 package from 
Bioconductor. Differential gene expression analysis was performed using edgeR 3.20.9 in a 
pairwise manner among all conditions, and a total of 12,240 DEGs were defined with a p-
value ≤ 0.001 and ≥4-fold difference. To construct the correlation plot, Euclidean distance among 
samples were calculated based on the differential expression matrix and clustering was 
performed using the ward.D2 algorithm in R. CNS/PNS shared, PNS-specific, and CNS-specific 
genes were determined by subclustering the DEGs based on the expression pattern with a 
refined k-mean clustering using R followed by manual curations. Expression data was visualized 
using Morpheus (https://software.broadinstitute.org/morpheus). For neuronal microenvironment 
analysis, only the transcriptome profile of macrophages and microglia from PNS and CNS were 
used and analyzed through the same pipeline as mentioned above. 
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Comparison of published microglia data 
External datasets for circos plot were obtained from Krasemann et al. 6. Genes that are 
enriched in SOD1G93A, aging brain, MFP2−/−, brain irradiation, AD (5XFAD), and phagocytic 
microglia conditions were previously generated in Krasemann et al. 6. By comparing the PNS- 
and CNS-enriched genes with the disease signatures, we were able to define the number of 
conditions shared by the genes and coined the term as “connectivity”. Only genes with 
connectivity of two or above are shown in the circos plot. For the comparison with Sall1−/− data 
set 21, the log2 fold change of genes between CNS microglia and PNS macrophages were 
calculated and compared against the public data set. Correlation coefficient and p-value were 
calculated by lineregress in Scipy using Python3. 
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Figure 1. PNS macrophages are in close contact with Schwann cells, vasculature, and endoneurial 
fibroblasts. a Confocal imaging of PNS macrophages in close contact with Schwann cells in transverse 
section of sciatic nerve from CX3CR1GFP/+MPZtdTomato  mice. b PNS macrophages in close contact with 
DRG vasculature in CXCL12DsRed mice. c MHCII+ PNS macrophages in contact with PDPN+ 





Figure 2. Identification and characterization of PNS resident macrophages. a–c Representative 
confocal imaging of peripheral nerves from CX3CR1GFP/+MPZtdTomato mice (tomato from MPZ depicted 
here in blue). a Images of whole-mount dorsal root ganglia (DRG), cutaneous fascial (FN), vagal (VN), 
and sciatic nerves (SN) isolated from CX3CR1GFP/+ MPZtdTomato mice. Scale bars are 50 µm. b Endoneurial 
localization of GFP+ cells in longitudinal sections of sciatic nerves from 
CX3CR1GFP/+ MPZtdTomato mice. c CSF1R (red) and CX3CR1GFP (green) colocalization in sciatic nerve 
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cross sections. Scale bars are 50 µm. d Flow cytometric gating of CX3CR1GFP/+ cells from peripheral 
nerve tissues. e, f Representative expression of CD64 and CD45 in CX3CR1GFP/+ cells compared with 
brain microglia, large peritoneal macrophages (LPMs), and fluorescence minus one (FMO) 
control. g Flow cytometric quantification of CD45.1 and CD45.2 chimerism in blood (total T cells or total 
monocytes) and nerves from three pairs of wild-type (CD45.1) and Lyz2Cre tdTomato (CD45.2) 
parabionts 10 weeks after joining. h Representative imaging in peripheral nerves from wild-type 
parabiont; Scale bars are 100 µm. i–l Analysis of tdTomato expression in tamoxifen-pulsed CSF1RMer-iCre-
Mer × Rosa26-tdTomato mice. i Tamoxifen delivery schematic for fate mapping. Mice were given 
tamoxifen diet for 4 weeks and analyses for PNS macrophages and CNS microglia were performed at 0 
days and 8 weeks after tamoxifen diet removal. j tdTomato expression by genotype from combined 
peripheral nerves in tamoxifen-fed mice. k Flow cytometric quantification of Ly6c high and Ly6C low 
monocytes from mice bled at 0 days, 3 weeks, 4 weeks, and 8 weeks after tamoxifen removal. l Flow 
cytometric quantification of CNS microglia (brain and spinal cord) and PNS macrophages (pooled from 
DRG, fascial nerve, vagus nerve, and sciatic nerve to increase yield in analysis) 0 days and 8 weeks 
following tamoxifen removal. Data are mean ± SEM (n = 3 mice per time point). Source data are available 






Figure 3. PNS macrophage depletion with anti-CSF1R monoclonal antibody. a Confocal imaging of 
PNS macrophages in normal (left) and antibody treated (right) sciatic nerves from 
CX3CR1GFP/+MPZtdTomato  mice 10 days after i.p. injection. b Flow cytometric analysis of sciatic nerve and 
DRG macrophage depletion. c Expression of CD45 and CD64 in normal and remaining cells after CSF1R 





Figure 4. Analysis of resident macrophage chimerism in CD45.1 wild type and CD45.2 Lyz2-Cre 
tdTomato parabionts. Gating scheme (top) and representative flow plots of CD45.1 and CD45.2 





Figure 5. Flow cytometric analysis of blood and neural resident macrophages in pulse chase 
experiment. Gating strategy and representative flow plots of CNS microglia, blood monocytes, and PNS 













Figure 6. Gating strategy for identifying PNS macrophages and for double-sorted populations used 
in bulk-RNA sequencing. Representative gating schematic for flow cytometric identification and sorting 








Figure 7. PNS macrophages express microglial transcripts as well as a unique signature. a Sample 
correlation plot showing global transcriptomic analysis and hierarchical clustering of resident 
macrophages from PNS, CNS, and conventional macrophages. Each box represents one replicate. Three 
replicates comprising up to 20 mice per replicate were included for each population. b Visualization of 
PNS macrophage unique transcripts (upper quadrant), CNS microglia unique transcripts (right quadrant), 
shared transcripts between PNS macrophages and CNS microglia (diagonal, top right quadrant), and 
conventional macrophages (bottom right quadrant). c Expression of microglial core transcripts in 
combined PNS macrophages compared with combined conventional macrophages. Multiple t-tests. Data 
are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. d GO analysis of genes enriched 
in PNS macrophages and CNS microglia. e GO analysis of genes enriched in PNS 
macrophages. f Transcripts expressed at least fourfold higher in PNS macrophages and CNS microglia 
than conventional tissue-resident macrophages (p ≤ 0.05). g Transcripts expressed at least fourfold higher 
in PNS macrophages than CNS microglia or conventional macrophages (p ≤ 0.05). f, g Each box 
represents average of three replicates. Abbreviations: LPM, large peritoneal macrophage; SPM, small 
peritoneal macrophage. Source data are available as a Source Data file. 
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Table 1. Gene ontology analysis of enriched transcripts shared by CNS microglia and PNS 
macrophages. 
 
GO term Description P-value FDR q-value Enrichment (N, B, n, b) 
GO:0050804 modulation of chemical 
synaptic transmission 
3.01E-09 4.02E-05 5.92 (9205,247,107,17) 
GO:0099177 regulation of trans-synaptic 
signaling 
3.20E-09 2.14E-05 5.90 (9205,248,107,17) 
GO:0048870 cell motility 2.24E-06 9.97E-03 3.41 (9205,480,107,19) 
GO:0040011 locomotion 2.30E-06 7.67E-03 3.26 (9205,528,107,20) 
GO:0016477 cell migration 1.43E-05 3.82E-02 3.26 (9205,448,107,17) 
GO:0048247 lymphocyte chemotaxis 1.84E-05 4.09E-02 14.83 (9205,29,107,5) 
GO:0023051 regulation of signaling 3.52E-05 6.72E-02 1.88 
(9205,1741,107,38) 
GO:0008347 glial cell migration 4.66E-05 7.77E-02 19.12 (9205,18,107,4) 
GO:0006935 chemotaxis 5.00E-05 7.41E-02 4.70 (9205,183,107,10) 
GO:0048167 regulation of synaptic 
plasticity 
5.09E-05 6.79E-02 6.04 (9205,114,107,8) 
GO:0042330 taxis 5.74E-05 6.96E-02 4.63 (9205,186,107,10) 
GO:0030334 regulation of cell migration 5.78E-05 6.43E-02 2.81 (9205,551,107,18) 
GO:0051272 positive regulation of cellular 
component movement 
6.01E-05 6.17E-02 3.38 (9205,356,107,14) 
GO:0040012 regulation of locomotion 6.39E-05 6.10E-02 2.69 (9205,608,107,19) 
GO:0030595 leukocyte chemotaxis 6.41E-05 5.71E-02 6.92 (9205,87,107,7) 
GO:0051270 regulation of cellular 
component movement 
6.83E-05 5.70E-02 2.68 (9205,611,107,19) 
GO:0010646 regulation of cell 
communication 
7.32E-05 5.75E-02 1.84 
(9205,1729,107,37) 
GO:0040017 positive regulation of 
locomotion 
7.64E-05 5.66E-02 3.31 (9205,364,107,14) 
GO:2000145 regulation of cell motility 9.16E-05 6.44E-02 2.71 (9205,571,107,18) 
GO:0072676 lymphocyte migration 1.17E-04 7.79E-02 10.24 (9205,42,107,5) 
GO:0048246 macrophage chemotaxis 1.22E-04 7.75E-02 28.68 (9205,9,107,3) 
GO:0090128 regulation of synapse 
maturation 
1.22E-04 7.40E-02 28.68 (9205,9,107,3) 
GO:0060326 cell chemotaxis 1.36E-04 7.89E-02 5.25 (9205,131,107,8) 
GO:0002687 positive regulation of 
leukocyte migration 
1.55E-04 8.64E-02 6.02 (9205,100,107,7) 
GO:0030335 positive regulation of cell 
migration 
1.63E-04 8.68E-02 3.26 (9205,343,107,13) 
GO:2000147 positive regulation of cell 
motility 
1.93E-04 9.91E-02 3.20 (9205,349,107,13) 
GO:0006928 movement of cell or 
subcellular component 
2.01E-04 9.92E-02 2.47 (9205,663,107,19) 
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GO:0001934 positive regulation of protein 
phosphorylation 
2.03E-04 9.69E-02 2.64 (9205,554,107,17) 
GO:0010562 positive regulation of 
phosphorus metabolic process 
2.19E-04 1.01E-01 2.53 (9205,612,107,18) 
GO:0045937 positive regulation of 
phosphate metabolic process 
2.19E-04 9.77E-02 2.53 (9205,612,107,18) 
GO:1905517 macrophage migration 2.35E-04 1.01E-01 23.46 (9205,11,107,3) 
GO:0042327 positive regulation of 
phosphorylation 
3.63E-04 1.52E-01 2.51 (9205,582,107,17) 
GO:0032879 regulation of localization 3.98E-04 1.61E-01 1.81 
(9205,1524,107,32) 
GO:0032430 positive regulation of 
phospholipase A2 activity 
3.99E-04 1.57E-01 57.35 (9205,3,107,2) 
GO:0071310 cellular response to organic 
substance 
4.34E-04 1.66E-01 2.25 (9205,763,107,20) 
GO:0051966 regulation of synaptic 
transmission, glutamatergic 
4.83E-04 1.79E-01 10.75 (9205,32,107,4) 
GO:0050921 positive regulation of 
chemotaxis 
6.05E-04 2.18E-01 5.74 (9205,90,107,6) 
GO:0050900 leukocyte migration 6.10E-04 2.14E-01 4.82 (9205,125,107,7) 
GO:0072677 eosinophil migration 6.28E-04 2.15E-01 17.21 (9205,15,107,3) 
GO:0048245 eosinophil chemotaxis 6.28E-04 2.10E-01 17.21 (9205,15,107,3) 
GO:0032103 positive regulation of response 
to external stimulus 
6.60E-04 2.15E-01 3.74 (9205,207,107,9) 
GO:0051897 positive regulation of protein 
kinase B signaling 
7.39E-04 2.35E-01 6.94 (9205,62,107,5) 
GO:1904141 positive regulation of 
microglial cell migration 
7.91E-04 2.46E-01 43.01 (9205,4,107,2) 
GO:0050769 positive regulation of 
neurogenesis 
8.05E-04 2.44E-01 3.10 (9205,305,107,11) 
GO:2001237 negative regulation of extrinsic 
apoptotic signaling pathway 
8.55E-04 2.54E-01 6.72 (9205,64,107,5) 
GO:0045860 positive regulation of protein 
kinase activity 
9.11E-04 2.65E-01 3.28 (9205,262,107,10) 
GO:0008284 positive regulation of cell 
proliferation 
9.46E-04 2.69E-01 2.48 (9205,520,107,15) 
GO:0050920 regulation of chemotaxis 9.63E-04 2.68E-01 4.46 (9205,135,107,7) 
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Table 2. Gene ontology analysis of enriched transcripts in PNS macrophages. 
 
GO term Description P-value FDR q-value Enrichment (N, B, n, b) 
GO:0001568 blood vessel development 6.64E-10 8.87E-06 15.47 (9203,85,70,10) 
GO:0051271 negative regulation of 
cellular component 
movement 
1.04E-05 6.96E-02 6.36 (9203,186,70,9) 
GO:0040013 negative regulation of 
locomotion 
1.40E-05 6.24E-02 6.13 (9203,193,70,9) 
GO:2000145 regulation of cell motility 1.93E-05 6.43E-02 3.45 (9203,571,70,15) 
GO:0032879 regulation of localization 2.62E-05 7.01E-02 2.24 (9203,1525,70,26) 
GO:0001525 angiogenesis 3.45E-05 7.68E-02 6.34 (9203,166,70,8) 
GO:0040012 regulation of locomotion 4.02E-05 7.66E-02 3.24 (9203,608,70,15) 
GO:0051270 regulation of cellular 
component movement 
4.25E-05 7.10E-02 3.23 (9203,611,70,15) 
GO:0030199 collagen fibril organization 5.48E-05 8.12E-02 18.78 (9203,28,70,4) 
GO:0030334 regulation of cell migration 5.53E-05 7.38E-02 3.34 (9203,551,70,14) 
GO:0070208 protein heterotrimerization 8.83E-05 1.07E-01 32.87 (9203,12,70,3) 
GO:0032102 negative regulation of 
response to external stimulus 
1.16E-04 1.29E-01 5.34 (9203,197,70,8) 
GO:0043589 skin morphogenesis 1.70E-04 1.75E-01 87.65 (9203,3,70,2) 
GO:0021637 trigeminal nerve structural 
organization 
1.70E-04 1.62E-01 87.65 (9203,3,70,2) 
GO:0030336 negative regulation of cell 
migration 
1.72E-04 1.53E-01 5.90 (9203,156,70,7) 
GO:2000146 negative regulation of cell 
motility 
2.34E-04 1.96E-01 5.61 (9203,164,70,7) 
GO:0009653 anatomical structure 
morphogenesis 
2.86E-04 2.24E-01 2.72 (9203,724,70,15) 
GO:0030510 regulation of BMP signaling 
pathway 
3.03E-04 2.25E-01 12.23 (9203,43,70,4) 
GO:0048646 anatomical structure 
formation involved in 
morphogenesis 
3.16E-04 2.22E-01 3.42 (9203,423,70,11) 
GO:0030513 positive regulation of BMP 
signaling pathway 
3.17E-04 2.11E-01 21.91 (9203,18,70,3) 
GO:0032489 regulation of Cdc42 protein 
signal transduction 
3.39E-04 2.15E-01 65.74 (9203,4,70,2) 
GO:0021785 branchiomotor neuron axon 
guidance 
3.39E-04 2.06E-01 65.74 (9203,4,70,2) 
GO:0071230 cellular response to amino 
acid stimulus 
3.94E-04 2.28E-01 11.43 (9203,46,70,4) 
GO:1902531 regulation of intracellular 
signal transduction 
5.37E-04 2.99E-01 2.37 (9203,942,70,17) 
GO:0006930 substrate-dependent cell 
migration, cell extension 
5.62E-04 3.00E-01 52.59 (9203,5,70,2) 
 44 
GO:0048820 hair follicle maturation 5.62E-04 2.89E-01 52.59 (9203,5,70,2) 
GO:0043200 response to amino acid 6.31E-04 3.12E-01 10.11 (9203,52,70,4) 
GO:0009966 regulation of signal 
transduction 
6.86E-04 3.27E-01 1.97 (9203,1538,70,23) 
GO:0043062 extracellular structure 
organization 
7.34E-04 3.38E-01 5.52 (9203,143,70,6) 
GO:0060976 coronary vasculature 
development 
7.61E-04 3.38E-01 16.43 (9203,24,70,3) 
GO:0048568 embryonic organ 
development 
8.26E-04 3.56E-01 6.78 (9203,97,70,5) 
GO:0090263 positive regulation of 
canonical Wnt signaling 
pathway 
8.37E-04 3.49E-01 9.39 (9203,56,70,4) 
GO:0003214 cardiac left ventricle 
morphogenesis 
8.39E-04 3.39E-01 43.82 (9203,6,70,2) 
GO:0021612 facial nerve structural 
organization 
8.39E-04 3.29E-01 43.82 (9203,6,70,2) 
GO:0032101 regulation of response to 
external stimulus 
9.63E-04 3.67E-01 2.99 (9203,483,70,11) 






Figure 8. Uniquely downregulated genes in neural resident macrophages. Heat map of mRNA 
transcripts fourfold or more downregulated in CNS microglia and PNS macrophages compared to 








Figure 9. Examination of Sall1 expression in PNS macrophages. Flow cytometry analysis of GFP 
expression in brain microglia, DRG macrophages, and sciatic nerve macrophages isolated from Sall1-























Figure 10. Identification of unique signatures in CNS microglia. Heat map of transcripts selectively 
enriched fourfold or more in brain and spinal cord microglia compared to PNS and conventional 




Figure 11. Downregulated genes in PNS macrophages. Heat map of genes that are downregulated 
fourfold or more in PNS macrophages compared to all other populations combined. Each box represents 







Figure 12. Unique gene expression patterns in individual PNS macrophage populations. Heat map of 
upregulated and downregulated mRNA transcripts in single PNS macrophage populations by fourfold or 
more in sciatic, fascial, and vagal nerves and eightfold or more in DRG relative to their expression in the 






Figure 13. PNS macrophages constitutively express transcripts associated with activated microglia. 
a Expression pattern of DEGs defined as PNS-enriched (red) or CNS-enriched (blue). CNS microglia 
includes brain and spinal cord and PNS macrophages include DRG, vagal, fascial, and sciatic 
nerves. b Circos plot showing the number of connections (gene connectivity) between GSEA-scored 
genes from microglia in 6 neurodegenerative and aging-associated conditions as defined in Krasemann et 
al.6 and neural macrophage-enriched genes from either PNS macrophages (red) or CNS microglia 
(blue). c PNS-enriched genes from connectivity groups 6–4 expressed as Log2 fold change (PNS 
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macrophages/CNS microglia). d Expression plot comparing PNS macrophage-enriched genes (expressed 
as PNS macrophage/CNS microglia Log2FC) and Sall1−/− microglia-enriched genes (expressed as 
Sall1−/−/wild-type microglia Log2FC) from Buttgereit et al.; r, correlation coefficient; p, p-value for linear 
regression analysis. e Representative immunohistochemistry in sciatic nerves of CX3CR1GFP/+ mice 
showing DAPI (blue), GFP (green), MHCII (white), and Clec7a (red). Scale bar, 50 µm. Source data are 





Figure 14. Comparison of phagocytic capacity in brain microglia and sciatic nerve macrophages. 
Flow cytometric analysis of fluorescent bead uptake by brain microglia and sciatic nerve macrophages 









Figure 15. Zonation of PNS macrophage-enriched transcripts in neural resident macrophages. 
a Heat map showing genes corresponding to PNS to CNS zonation pattern (PNS macrophages high, 
spinal cord microglia high/intermediate, brain microglia low). Each box represents average from three 
replicates. b Gene expression analysis of individual genes following PNS to CNS zonation pattern. Each 
dot represents one replicate. Unpaired t-test. Data are mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, 
****P < 0.0001. c Representative Clec7a staining in brain (Br), spinal cord (SC), dorsal root ganglia 
(DRG), and sciatic nerve (SN) of CX3CR1GFP/+ mice. Scale bars are 100 µm. Source data are available as 






Figure 16. Clec7a+ microglia localization in spinal cord. IHC analysis of CLEC7A expression by 





Figure 17. Expression of microglial homeostatic genes in spinal cord and brain microglia. Log2 
expression of microglial homeostatic genes in brain (green) and spinal cord (magenta) microglia. Multiple 
t tests. Data are mean of three replicates +/- SEM with adjusted p-value shown. * P < 0.05, ** P < 0.01, 




3. Ontogeny of peripheral nerve resident macrophages 
The work described in this chapter was published in the journal Nature Communications under 
the following citation: 
 
Wang PL, Yim AKY, Kim KW, Avey D, Czepielewski RS, Colonna M, Milbrandt J, Randolph 
GJ. Peripheral nerve resident macrophages share tissue-specific programming and features of 
activated microglia. Nat Commun. 2020 May 21;11(1):2552. 
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      While all tissue resident macrophages arise from erythro-myeloid progenitors (EMP) that 
form in the embryonic yolk sac by embryonic day E8.5 (YS), only CNS microglia are thought to 
remain predominantly YS-derived in throughout life, without contribution from the fetal liver or 
definitive hematopoiesis 1-3. In all other known tissues, including lung, liver, pancreas, kidney, 
and heart, YS precursors are mostly or entirely replaced by fetal liver monocytes before birth 1. 
In some tissues, such as gut and dermis, fetal liver monocytes are further replaced by bone 
marrow monocytes in a CCR2-dependent manner before and during adulthood 1,4.   
The realization that macrophages arise from different sources raises key questions about 
macrophage replacement in disease contexts. For example, could dysfunctional or overly 
inflammatory microglia in CNS diseases be replaced, and if so, from which source? Studies to 
address this question have found that when hematopoietic stem cell (HSC)-derived macrophage 
precursors were transplanted into the brains of mice that lack resident microglia, these cells took 
on a more activated transcriptional signature compared to normal microglia 5,6. Notably, these 
cells also expressed microglial homeostatic signatures, but not to the extent of their YS-derived 
counterparts 5. While the beneficial or detrimental effects of microglial transplantation still 
remain to be worked out, these observations suggest that both developmental source and brain 
environment mediates the expression of microglial signatures.  
Considering the growing interest in how tissue environment and ontogeny contribute to 
microglial identity and function in neurological diseases, we investigated these questions in PNS 
macrophages for the first time. We found that PNS macrophages originate from both embryonic 
and hematopoietic sources in mice. Peripheral nerves were fully populated by macrophages at 
birth and included a subpopulation of YS-derived cells. PNS macrophages also exhibit partial 
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dependence on IL-34, an alternative ligand for colony-stimulating factor 1 receptor (CSF1R) that 
is important for the development and maintenance of microglia 7,8, and do not depend on CCR2 
signaling to seed peripheral nerves. With the exception of Ccr2 expression, transcriptional 
signatures in PNS macrophage were largely similar between embryonic and hematopoietic 
sources, suggesting that nerve environment controls their identity at steady state. 
 
3.2 Results 
3.2.1 Identification of embryonic- and HSC-derived PNS resident 
macrophages 
In addition to microenvironmental cues, ontogeny may also play an important role for 
specifying microglial identity and function. Specifically, it has been shown that, compared to 
naturally occurring microglia with yolk sac origin, monocyte- and hematopoietic stem cell 
(HSC)-derived microglia display a more activated signature 5,6. Thus, we sought to determine 
PNS macrophage ontogeny by examining Flt3Cre × LSL-YFPfl/fl reporter mice (Fig. 18a), a 
strain that labels fetal monocyte and adult HSC-derived hematopoietic multipotent progenitors 
and their progeny 2,9. We found that ~26% of PNS macrophages across nerve types appeared to 
be embryonically derived (YFP−) and 74% of PNS macrophages were HSC-derived (YFP+) 
(Fig. 18b and Fig. 19). 
To further examine the contribution of embryonic precursors to PNS macrophages, we 
performed fate mapping using CSF1RMer-iCre-Mer × tdTomatofl/fl × CX3CR1GFP/+ double reporter 
mice, which allows simultaneous visualization of tamoxifen-pulsed CSF1R-expressing 
macrophages and resident Cx3cr1+ macrophages. After giving tamoxifen at embryonic day 8.5 
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(E8.5), a developmental time point that labels yolk-sac derived macrophages, we checked 
newborn pups for labeling. The PNS was fully populated with CX3CR1GFP/+ macrophages at 
birth. In line with previous observations 10, we observed partial labeling in 42% of brain 
microglia (Fig. 18c, d). Labeling in PNS macrophages was 8% from SN and DRG, or roughly 
one-fifth of the entire PNS macrophage population when normalized to microglia (Fig. 18c, d). 
Less than 1% of macrophages were tdTomato+ in spleen, kidney, and blood, and only 3% of 
lung macrophages were tdTomato+ (Fig. 18c, d and Fig. 20). These results demonstrate that the 
PNS is fully populated by macrophages at the time of birth and that a subset of these cells are 
derived from yolk sac progenitors. 
 
3.2.2 PNS macrophage seeding depends on IL-34 but not CCR2 
Although monocyte entry into injured nerves depends on CCR2 11,12, it is not known 
whether CCR2 is required for seeding or maintaining the PNS macrophage niche. To address this 
question, we quantified CSF1R+ macrophages in SNs of CCR2 knock-in (CCR2GFP/GFP) and 
control (CCR2GFP/+) mice. We observed no difference in PNS macrophage numbers between 
CCR2 knockouts and controls (Fig. 18e-g). However, although GFP+ cells were present in SNs 
from CCR2GFP/+ mice, GFP+ cells were almost entirely absent from CCR2GFP/GFP mice (Fig. 18e, 
f and Fig. 21). These observations suggest that CCR2-dependent monocyte entry is not required 
to fill or maintain the PNS macrophage niche, but may contribute to a modest subset of PNS 
macrophages at steady state. 
Given the resemblance between microglia and PNS macrophages, we wondered if IL-34, 
an alternative ligand for CSF1R that contributes to CNS microglia homeostasis 7,8, likewise 
governs PNS macrophage numbers. We quantified PNS macrophages of IL-34 deficient mice 
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(IL-34LacZ/LacZ) by flow cytometry and imaging. In the SN, the fraction of CD45+ cells in the 
disaggregated nerve was reduced by a 30% (Fig.18h-i), apparently owing to more than 50% 
reduction in PNS macrophage density per nerve area, as examined by imaging the intact nerve 
(Fig. 18j-k). In the DRG, we observed a reduction in macrophage density of more than 35% (Fig. 
22), underscoring significant dependence on IL-34 in multiple PNS sites. Indeed, this fraction of 
loss resembles that observed in the CNS microglial population 7,8. 
In the SN, we checked expression of IL-34 mRNA transcripts by in-situ hybridization 
(ISH). Surprisingly, we found that Prx-expressing myelinating Schwann cells were a source of 
IL-34 (Fig. 18l). In the absence of IL-34, PNS macrophages in the SN showed increased surface 
marker expression of CD45 and CD11b, suggesting a shift in phenotype further away from 
microglial characteristics (Fig. 18m). Taken together, these results reveal shared and unique 
developmental programs, including instructive cytokines, between PNS macrophages and CNS 
microglia. 
 
3.2.3 Nerve environment shapes transcriptional identity of PNS macrophages  
To investigate the extent to which PNS macrophage identity is specified by ontogeny or 
nerve environment, we individually sorted YFP− embryonic-derived and YFP+ HSC-derived 
PNS macrophages from SNs of Flt3Cre LSL-YFPfl/fl mice and performed single-cell RNA-seq 
(Fig. 23a). We captured a total of 935 YFP− cells and 3186 YFP+ cells. Unsupervised clustering 
analysis of all 4121 cells revealed 5 separate clusters, with the majority of PNS macrophages 
belonging to one major group (clusters 1, 2, and 3) and the remainder falling into 2 smaller 
clusters (4 and 5) (Fig. 23b). 
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Although we observed a significant overlap of YFP− and YFP+ macrophages in clusters 
1, 3, 4, and 5, cluster 2 contained mostly YFP+ macrophages (Fig. 23b). Interestingly, cluster 2 
was defined by Ccr2 expression, which is consistent with this subset arising from circulating 
precursors (Fig. 23c). Indeed, we confirmed by flow cytometry that CCR2+ PNS macrophages 
were only found in the YFP+ fraction (Fig. 23f and Fig. 24). We also observed varying 
heterogeneity between the overlapping clusters (Fig. 23c). For instance, cluster 5 was easily 
distinguished by proliferation genes Mki67 and Top2a. Cluster 4 was also relatively distinct and 
showed enrichment for Ly6e, Ninj1, Retnla, and Wfdc17, potentially representing a previously 
undescribed activation state. Cluster 3 selectively expressed early activation genes Fos, Jun, 
and Egr1. Cluster 1 was slightly enriched for Lyve1 expression compared to cluster 2 (Fig. 23c). 
We confirmed Lyve1 expression in a subset of PNS macrophages by immunostaining (Fig. 23g). 
Interestingly, we also saw axonal expression of YFP in Flt3-Cre LSL-YFP mice (Fig. 23g), 
which is in accordance with previous findings that Flt3 is expressed in neurons and may play a 
role in neural stem cell proliferation and survival 13.  
Despite the identification of separate clusters in our data, we observed no obvious 
difference in the expression of PNS macrophage-enriched or microglial activation-associated 
transcripts between the main clusters. Specifically, Apoe, Cp, H2-Aa, Cd74, Ms4a6c, Ifitm3, 
Anxa5, Cybb, and Cd52 were nearly identical between clusters 1, 2, and 3 (Fig. 23d). We also 
observed no difference in Cx3cr1 and Trem2 between these clusters. Importantly, all of these 
genes were similarly expressed between YFP− and YFP+ macrophages (Fig 23e). We conclude 
that embryonic- and HSC-derived PNS macrophages are transcriptionally similar and that the 





Here we demonstrate that both embryonic and HSC-derived PNS macrophages exist as 
transcriptionally similar populations in adult nerves regardless of origin, thus suggesting a more 
important role for nerve environment than ontogeny in programming neural resident 
macrophages at steady state. While these results imply that there exists a subset of PNS 
macrophages that more closely resembles microglia by way of embryonic origin, future 
experiments are needed to determine if this more primitive subset behaves differently compare 
with HSC-derived macrophages in the PNS. Interestingly, we and others have found that a subset 
of macrophages similar in proportion to those which are embryonic-derived remains in 
peripheral nerves after lethal irradiation and bone marrow transfer 14,15. As microglia are known 
to be radio-resistant 16, this raises the question of whether embryonic-derived PNS macrophages 
are more radio-resistant compared with HSC-derived counterparts.  
From the observation that PNS macrophages are reduced and more activated in IL-34 KO 
mice, a similar question that arises is whether IL-34 deficiency specifically depletes embryonic-
derived macrophages. Also, is loss of CSF-1 but preservation of IL-34 sufficient to maintain 
PNS macrophages, and if so, to what extent? By modeling PNS macrophage deficiency, these 
mouse strains may be further useful for examining the roles of PNS macrophages in 
development, injury response, and neuroprotection.  
Future experiments are also needed to examine whether there are differential roles 
between embryonic and HSC-derived resident macrophage populations as well as recruited 
monocytes in neuropathic conditions. Indeed, studies in heart macrophages, which likewise 
identify CCR2- embryonic and CCR2+ HSC-derived subsets, indicate that these two populations 
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respond differently after heart injury with CCR2- macrophages facilitating regeneration and 
CCR2+ macrophages contributing to monocyte recruitment and inflammatory responses 17,18. 
These and other models may be useful for dissecting the relative contribution of embryonic- and 
HSC-derived PNS macrophages after nerve injury. 
Lastly, the observation that the majority of PNS macrophage signatures were expressed 
independent of ontogeny suggests that PNS macrophage signatures are strongly influenced by 
neuronal environment. This is the subject of the next chapter.  
   
3.4 Materials and methods 
Experimental animals 
Mouse care and experiments were performed in accordance with protocols approved by 
the Institutional Animal Care and Use Committee at Washington University in St. Louis under 
the protocols 20170154 and 20170030. Mice were kept on a 12 h light–dark cycle and received 
food and water ad libitum. The following strains were used: C57/B6 CD45.1 (stock number 
002014), CX3CR1GFP/+(Cx3cr1tm1Litt/LittJ; stock number 008451), and CSF1RMer-iCre-Mer mice 
were obtained from JAX (stock number 019098). Flt3-Cre LSL-YFPfl/fl 9 mice were kindly 
provided by D. Denardo, CCR2gfp/+ (B6(C)-Ccr2tm1.1Cln/J, (JAX stock number 027619) mice were 
kindly provided by K. Lavine, and IL34LacZ/LacZ mice were previously described and generated at 
Washington University 7. 
 
Immunohistochemistry 
For whole-mount imaging, samples were harvested and immediately stored in 4% 
paraformaldehyde (PFA) containing 40% sucrose overnight. Samples were then washed in 
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phosphate-buffered saline (PBS), blocked, stained, and imaged. For frozen sections, samples 
were collected, stored in PFA/sucrose, and embedded into optimal cutting 
temperature compound. Fifteen-micrometer cuts were made for SNs. Sections were then blocked 
in 1% bovine serum albumin, stained, and imaged. Antibodies to the following proteins were 
used: anti-GFP, CSF1R (R&D Systems, accession number P09581), MHCII (IA/IE clone 
M5/114.15.2), and LYVE1 (ab14917). 
 
Preparation of single-cell suspensions 
For blood, mice were bled from the cheek immediately before killing and cells were 
prepared as previously described. For nerves and all other tissues, mice were killed and perfused 
with PBS. Nerves were collected and kept on ice until dissociation. Cells were then incubated 
with gentle shaking for 20 min in digestion media containing collagenase IV, hyaluronidase, and 
DNAse. Cells were then washed and filtered through 70 µm cell strainers. For brain and spinal 
cord, myelin was removed using a 40/80% Percoll gradient. 
 
Flow cytometry 
Single-cell suspensions were stained at 4 °C. Dead cells were excluded by propidium 
idodide (PI). Antibodies to the following proteins were used: B220 (clone RA3-6B2), CCR2 
(clone SA203G11), CD3e (clone 145-2C11), CD4 (clone RM4-5), CD8 (clone 53-6.7), CD11b 
(clone M1/70), CD16 (clone 2.4G2), CD45 (clone 30-F11), CD64 (clone X54-5/7.1), CD115 
(clone AFS98), GR1 (clone 1A8), and Ly6C (clone HK1.4). Cells were analyzed on a LSRII 




For sorting in preparation of the Flt3-Cre LSL-YFP single-cell Seq experiments, SNs 
from 19 male mice aged 10–12 weeks were combined and CD64+ CD45int macrophages were 
sorted individually into YFP+ and YFP− groups, yielding 18,000 and 5,000 cells, respectively. 




Homozygous CX3CR1-GFP female mice were rotated daily with CSF1RMer-iCre-
Mer tdTomato male mice and checked for plugs in the morning. Plug-positive females were 
administered 1.5 mg of 4-Hydroxytamoxifen (Sigma, catalog number H6278) and 1 mg of 
progesterone (Sigma, catalog number P0130) dissolved in corn oil by oral gavage 8 days 
following identification of plugs to pulse the embryos at embryonic 8.5 days. Following birth, 
pups were immediately sacrificed. Blood was collected for flow cytometric analysis and tissues 
were fixed in PFA/sucrose for imaging. 
 
Cell preparation, 10× single-cell library preparation, sequencing, and analyses 
A total of 4500 Flt3-negative and 16,000 Flt3-positive cells were loaded to separate lanes 
of the 10X Chip for preparation of two single-cell libraries. The library preparation was 
performed according to the manufacturer’s instructions (Chromium Single-cell v2; 10× 
Genomics, USA). A total of 153 M and 174 M reads were sequenced for Flt3-negative and Flt3-
positive libraries, respectively, using Illumina HiSeq2500. Reads were mapped by using the 
cellranger pipeline v2.1.1 onto the reference genome grcm38/mm10. We filtered cells for those 
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with ≥50,000 mapped reads, leaving ~1k Flt3-negative and 4k Flt3-positive cells. Downstream 
analyses were performed by using the package Seurat2 in R. 
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Figure 18. Shared and distinct developmental programs in PNS macrophages. a Schematic and flow 
cytometric gating for analysis of YFP expression in PNS macrophages from Flt3-Cre LSL-YFP sciatic 
nerves. b Comparison of YFP− macrophage ratios (expressed as % YFP− cells of population) across 
neural resident macrophage populations, monocytes, B cells, and T cells (n = 4−7 mice per group). c E8.5 
tdTomato labeling and GFP expression in brain (left panel), sciatic nerve (middle panel), and DRG (right 
panel) of CSF1RMer-iCre-Mer × tdTomatofl/fl × CX3CR1GFP/+ mice. Scale bar, 100 µm. d Quantification of 
E8.5 tdTomato labeling in brain, PNS, spleen, lungs, kidney, and blood from newborn pups (n = 2 mice 
for blood analysis, n = 3 mice for tissue analysis). e Histological representation of PNS macrophages in 
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CCR2GFP/GFP sciatic nerves. Scale bar, 100 µm. f Quantification of CCR2+ CSF1R+ macrophages in 
sciatic nerves in CCR2GFP/+ and CCR2GFP/GFP mice (n = 5 mice per group). g Quantification of total 
CSF1R+ macrophages in CCR2GFP/+ and CCR2GFP/GFP mice (n = 5 mice per group). h Flow cytometric 
gating and (i) analysis of sciatic nerve macrophages from wild type (WT) and IL-34 knockout (KO) mice 
(n = 3 mice per group). j Quantification of sciatic nerve macrophages in WT and IL-34 KO mice (n = 3 
mice per group). Scale bar, 100 µm. k Representative imaging of WT and IL-34 KO sciatic nerves. 
CSF1R staining in green. Scale bar, 120 µm. l In-situ hybridization in WT sciatic nerve showing IL-34 
colocalization with Prx-expressing Schwann cell. Scale bar, 50 µm. m CD11b and CD45 expression in 
PNS macrophages from WT (red) and IL-34LacZ/LacZ (blue) mice. For imaging quantification, at least three 
images were taken and analyzed from each tissue and averages from each group were plotted. Each dot 
represents one mouse. All data are mean ± SD. Data comparing wild type and knockouts analyzed by 
unpaired t-test. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; NS, not significant. Source data are 






Figure 19. Flow cytometric gating of blood and CNS populations in Flt3-Cre LSL-YFP. Gating 
strategy for determining YFP- and YFP+ percentages in monocytes, B cells, T cells, brain microglia, and 





Figure 20. Embryonic day 8.5 labeling in blood and non-neuronal tissues. Flow cytometric gating of 
tdTomato labeling in blood and representative imaging of spleen, lung, and kidney of CSF1RMer-iCre-Mer x 








Figure 21. CCR2 is not required for seeding and maintaining PNS macrophages. Representative 
imaging of total CSF1R+ and CCR2+ macrophages in sciatic nerve sections of CCR2GFP/+ and CCR2GFP/GFP 













Figure 22. DRG macrophages are reduced in IL-34 KO mice. Representative imaging of Iba1+ 
macrophages (red) in DRG and quantification of macrophages. At least 3 images were analyzed and 














Figure 23. Nerve environment shapes transcriptional identity of PNS macrophages. a Schematic for 
isolation and separate single-cell RNA sequencing of YFP− embryonic and YFP+ HSC-derived 
macrophages from sciatic nerves of Flt3-Cre LSL-YFPfl/fl mice. Two single-cell libraries from YFP− and 
YFP+ macrophages were prepared using the 10× single-cell RNA-seq platform (Chromium Controller 
image provided by 10× Genomics). b t-SNE plot of 4121 CD64+ CD45int cells from pooled sciatic 
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nerves (n = 18) showing unsupervised clustering (left panel) and overlay of YFP− (red) and YFP+ (blue) 
populations (right panel). c, d t-SNE plots depicting distribution of (c) transcripts relating to clusters in b 
and (d) transcripts associated with microglial activation across combined embryonic and HSC-derived 
PNS macrophages. e Violin plots of marker gene expression in YFP+ HSC-derived and YFP− embryonic 
groups. f Flow cytometric identification of CCR2+ macrophages in a subset of YFP+ macrophages. 
Gating is representative of at least seven nerves examined over three separate experiments. G 
Representative imaging of a subset of Lyve1+ macrophages in Flt3-Cre LSL-YFPfl/fl mouse sciatic nerve. 








Figure 24. Quantification of CCR2+ subsets in YFP+ and YFP- macrophages in Flt3-Cre LSL-
YFP mice. Gating scheme for identification and analysis of CCR2+ and CCR2- macrophages as a 











4. Nerve environment influence on PNS macrophages 
The work described in this chapter is unpublished. 
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The unique functionality of the nervous system can be attributed to the cells that 
comprise it. Both the PNS and CNS are made up of neurons, glia, resident macrophages, stromal 
cells, and endothelial cells, which together determine the nerve environment.  
Studies in mice show that CNS microglia rapidly lose their transcriptional signature if 
taken out of the brain 1,2. CNS-naïve cells also rapidly take on a microglia signature when 
transplanted into the brain 2-4. These findings demonstrate that intrinsic tissue factors critically 
shape microglial phenotypes. Indeed, a known key regulator for microglia is TGF-β signaling, 
which not only confers expression of microglial signature genes, but is also required for 
microglia development and homeostasis 5.  
Another intrinsic feature of the nervous system is myelin. Structurally, myelin is 
comprised of a mixture of proteins and phospholipids that insulate nerve fibers and increase the 
speed of electrical impulses 6. In the CNS, myelin is produced by oligodendrocytes, while in the 
PNS, myelin is produced by Schwann cells. It has been reported that CNS microglia signatures 
differ between areas of grey matter, which contain mostly neuronal cell bodies and few 
myelinated axons, and areas of white matter, which contain mostly long-range myelinated axons 
and few neuronal cell bodies 7. Microglia in grey matter were shown to have higher expression 
of type1 interferon genes, while microglia in white matter were enriched for NF-κB pathway 
genes 8. Apart from injury conditions, it is currently unclear how myelin affects macrophage 
biology, either in the CNS or PNS. As the PNS contains diverse glia, including satellite glial 
cells surrounding the cell bodies of DRG neurons, and both myelinating and non-myelinating 
Schwann cells surrounding axons, it offers a unique opportunity to study how neural resident 
macrophages are affected by myelin or other glia-derived factors.    
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A number of extrinsic factors also contribute to the status of neuronal tissues. One 
example is neurotropic viruses, or viruses that are capable of infecting nerve cells. Indeed, 
neurotropic viruses have been common in humans over the course of evolutionary history 9. 
These include deadly viruses such as rabies and polio that have been successfully targeted by 
vaccines over the past century 10. The more common alpha herpesviruses include herpes simplex 
virus (HSV) species that primarily infect and either destroy or remain latent in sensory neurons 
11. According to estimates from the World Health Organization (WHO), HSV-1 and HSV-2, 
which causes oral and genital herpes, respectively infect 67% and 13% of people under the age 
of 49 worldwide 12. While HSV primarily infects peripheral neurons, they have been shown in 
both mice and humans to be able to translocate to the CNS 11,13. Interestingly, there is a long 
proposed link between viral infections and neurodegenerative diseases, which spans both 
peripheral neuropathies such as Guillain Barre syndrome as well as CNS diseases such as 
multiple sclerosis and Alzheimer’s disease 13-15. Yet, how viral infections affect PNS 
macrophages and their response in host protection is virtually unknown.  
Apart from infections, physical trauma is another highly prevalent and clinically 
important extrinsic factor that affects the nerve environment. When nerves are cut or crushed, the 
part of the axon distal to the injury degenerates, a process called Wallerian degeneration 16. Axon 
degeneration is followed by myelin sheath degradation and macrophage infiltration. While 
studies show that after nerve injury, PNS macrophages facilitate debris clearance, angiogenesis, 
SC maturation, and provide ROS to help with regeneration 17-20, how macrophages are 
themselves affected by the injured nerve environment is less clear. One clue may come from the 
basic function of phagocytosis. PNS macrophages have been shown to be critical for debris 
clearance through phagocytosis, not only of myelin, but also of cells undergoing apoptosis, a 
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process called efferocytosis 21. How macrophages process and respond to phagocytic cargo is 
therefore a topic of interest. Indeed, it has been shown that in both atherosclerotic lesions and 
CNS lesions, lipid-filled macrophages are important mediators that can decide the difference 
between pro-regenerative and anti-regenerative outcomes 22-24. How PNS macrophages 
accomplish these and the contextual factors that regulate their success or failure will be of 
interest for strategies aimed at improving regeneration and downstream outcomes.  
Here we build on our understanding of PNS macrophages to explore their phenotypes in 
models with perturbed nerve environments. We explore PNS macrophage responses and 
transcriptional signatures in nerves with dysregulated Schwann cells as well as in nerve injury. 
We show that phagocytic PNS macrophages adopt a unique signature associated with lipid-
handling that may have implications for neuroinflammation and regeneration.  
 
4.2 Results 
4.2.1 Schwann cell dysregulation induces macrophage expansion and 
reprogramming 
To study the link between nerve environment and PNS macrophage signatures, we 
examined mice lacking TSC2, a prime regulator of mTOR signaling that is often mutated in 
patients with tuberous sclerosis 25, in Schwann cells. We bred MPZ-Cre mice with TSC2 floxed 
mice to generate MPZ-Cre TSC2Fl/Fl mice (TSC2-SCKO mice). These mice manifest arrested 
Schwann cell development at the promyelinating stage and exhibit a massive increase in Sox10+ 
glia accompanied by severe hypomyelination and loss of nerve conduction 25 (Fig. 25 a,b). To 
label peripheral nerve macrophages in TSC2-SCKO mice, we crossed them to CX3CR1-GFP 
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mice. Upon examination of the sciatic nerve, we observed a remarkable 20-fold expansion of 
PNS macrophages (Fig. 25c). Consistent with the highly specific expression of MPZ in 
peripheral nerves 26, CNS microglia numbers did not appear to be significantly different (Fig. 
25c). These results show that PNS macrophage numbers are highly sensitive to perturbances in 
Schwann cells.  
We next sought to examine gene expression in macrophages from TSC2-SCKO mice. 
We sorted 1000 CX3CR1-GFP+ CD45int/low cells per replicate from sciatic nerves and brains of 
TSC2-SCKO and WT mice and performed RNA-seq. Interestingly, TSC2-SCKO macrophages 
had a significant reduction in previously identified PNS macrophage signatures (Cbr2,  Msr1, 
Ms4a7, C7bb, Clec7a, and Aoah) as well as genes involved in macrophage activation (Cd68) and 
immune response (Clec7a, Mrc1, Tlr4, and Tlr7) (Fig. 26a,b). TSC2-SCKO macrophages also 
had reduced expression of genes associated with endosomal/retromer functions, including 
several sorting nexin genes that have been shown to promote phagosome maturation 27,28 (Fig. 
26b). Upregulated transcripts in TSC2-SCKO macrophages included genes associated with 
neuronal connectivity/support and gli/hedgehog signaling (Fig. 26b). Surprisingly, microglial 
homeostatic genes, including Sall1, Tmem119, P2ry12, and Tgfbr1 were also increased in TSC2-
SCKO macrophages (Fig. 26c). Since the expression in microglial signatures, including Sall1, 
has been attributed to TGF-β signaling 1,5, we examined the correlation between Tgfbr1 and Sall1 
across our samples. Indeed, we found the expression of Sall1 to be directly correlated with 
Tgfbr1 expression across both sciatic nerve macrophage and brain microglia samples (Fig. 26d). 
Thus, PNS macrophages in TSC2-SCKO mice exhibit a unique transcriptional signature 
characterized by dysregulated cellular dynamics, reduced activation, and increased TGF-β 
responsiveness.  
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To examine macrophage heterogeneity in TSC2-SCKO mice, we performed single cell 
sequencing on sciatic nerve macrophages from these mice (Fig. 27a). Notably, microglial genes 
(Tmem119, Hexb, and P2ry12) were ubiquitously expressed in TSC2-SCKO macrophages (Fig. 
27b). However, we did observe differential gene expression between two subgroups of 
macrophages (Fig. 27c). Genes expressed in the first subgroup included Apoc1 and Apoc4, which 
are associated with monocyte-to-macrophage differentiation and lipid metabolism 29,30, Pf4, 
which is associated with the inhibition of angiogenesis 31, and Gas6, which is involved in the 
stimulation of cell proliferation and also the regulation of Schwann cell maturation by 
macrophages after nerve injury (Fig. 27c) 19. The second group expressed Il1b, Jun, and Cxcl12, 
which correspond with inflammation, and Ppp1r15a, which is associated with stressful growth 
arrest conditions (Fig. 27c) 32. Therefore, while most genes are homogeneously expressed in 
sciatic nerve macrophages in TSC2-SCKO, there is some polarization in genes related to cell 
cycle, lipid metabolism, and pro-inflammatory response. Taken together, our results suggest that 
PNS macrophages are uniquely responsive in TSC2-SCKO mice.  
 
4.2.2 PNS macrophage signatures in nerves with different myelin composition 
Given the association between increased microglial signatures and reduced myelination 
in the TSC2-SCKO mice, we sought to determine if myelination could be a significant regulator 
in the observed shift in gene expression. It has been reported that vagal nerves are less 
myelinated than sciatic nerves due to vagal nerves containing a higher composition of non-
myelinating Schwann cells than myelinating Schwann cells, with the opposite being true in 
sciatic nerves 33. Thus, we reasoned that if microglial activation genes are correlated with the 
 84 
extent of myelination, PNS macrophages in the sciatic should express more activated microglia 
signature genes and less microglial homeostatic genes.  
Using our previously generated data on PNS macrophages 34, we specifically compared 
gene expression in vagal and sciatic nerve macrophages. While we found 126 genes that were 
upregulated by 2-fold or more in sciatic nerves macrophages, we did not see any upregulation of 
microglial activation genes in this population (Fig. 28a). Instead, we found that sciatic nerve 
macrophages expressed genes related to fatty acid derivative transport (Anxa1, Abcc1, and 
Pla2g2d), angiogenesis (Plxnd1, Fgfr1, Ecm1, and Tgfbr3), and neural cell migration (Cxcl12, 
Ccdc141, Egfr, and Ndnf) (Fig. 28a and Table 1). In vagal nerves macrophages, we found 137 
genes that were upregulated by at least 2-fold (Fig. 28b). Remarkably, these included a wide 
range of genes involved in immune response, including genes involved in interferon response 
(Ifi47, Ifit2, Ifi204, Oasl2, and Stat1), antigen presentation (H2-T24, H2-Q4, H2-Q7, and H2-
Q6), response to biotic stimulus (Gbp6, Peli1, Axl, Cr2, and Herc6) (Fig. 28b). Indeed, many of 
the genes that were enriched in vagal nerve macrophages, including Axl, Cp, Apoe, and several 
interferon response genes have been linked to microglial activation 34. Interestingly, vagal nerve 
macrophages also exhibited increased expression of a number of homeostatic microglia genes, 
including Olfml3, Tmem119, Hexb and Tgfbr1 (Fig 28b). Taken together, these observations 
suggest that expression of microglial activation-associated genes in PNS macrophages is 
uniquely regulated and not simply explained by myelination. 
 
4.2.3 PNS macrophages in HSV infection 
Since the activation signature seen in PNS macrophages is highly associated with 
immune defense against pathogens, we reasoned that PNS macrophages may be responsive to 
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infections of the nervous system. Thus, we sought to examine the PNS macrophage response to 
infection with HSV, a highly common neurotropic virus that has evolved alongside humans and 
is responsible for oral and genital herpes infection. We started by infecting female mice 
intravaginally, a natural route of infection in humans, with HSV-1 and HSV-2 at a standard dose 
of 104 PFU per mouse 35. While it is known that both strains spread to sensory neurons of the 
dorsal root ganglia (DRG) after infection 35, it is unclear what happens in the sciatic nerve. 
Interestingly, we saw an early increase in sciatic nerve macrophages in both HSV-1 and HSV-2 
infected mice at 1 day post infection (Fig 29a). HSV-2 infected mice showed a further increase 
in sciatic nerve macrophages by day 5 (Fig. 29a). The expanded macrophages in sciatic nerves 
were highly positive for MHC-II (Fig. 29b). To further determine if virus was present in the 
sciatic nerve, we infected macrophage-labeled CX3CR1-CreER TdTomato mice with GFP-
tagged HSV-1 and imaged whole optically cleared nerves 10 days post infection. Remarkably, 
we saw strings of ameboid macrophages in proximal and distal sites of infected sciatic nerves 
containing what appeared to be GFP-positive virus (Fig. 29c). Indeed, this reflects published 
work on the ability of macrophages to trap HSV in multivesicular bodies to facilitate protection 
against severe disease 36. These results show that PNS macrophages are highly responsive to 
HSV infection and may function to control viral spread by phagocytosing infectious particles. 
 
4.2.4 Phagocytic activation of PNS macrophages after nerve injury 
To examine resident macrophage responses following nerve injury, we performed sciatic 
nerve crush in CX3CR1-CreER tdTomato mice and imaged nerves at different time points. Early 
crush (day 3) was associated with the appearance of CD68+ lysosomal staining in macrophages 
at the crush site (Fig. 30a). Interestingly, tdTomato+ resident macrophages appeared on the outer 
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region of the crush site (Fig. 30a), suggesting that the majority of macrophages at the injury core 
are monocyte-derived cells. Using CX3CR1-GFP/+ mice treated with anti-CSF1R monoclonal 
antibody to deplete resident macrophages, we observed that CX3CR1-GFP+ monocytes indeed 
infiltrate the injury site as well as distal regions of the nerve (Fig 30b). By day 7, CD68+ 
macrophages that actively phagocytose and degrade myelin in degenerating axons appear in 
distal regions where GFAP+ reactive SCs can be seen, but remain absent proximal to the crush 
site (Fig. 30c,d). Thus, phagocytosis and monocyte recruitment after nerve injury follows the 
spatial dynamics of Wallerian degeneration. 
Since phagocytic activation of macrophages after nerve injury was specific to 
degeneration, we wondered whether nerve breakdown was required for phagocytic activation in 
nerve macrophages. To test this, we compared the response of PNS macrophages to sciatic nerve 
transection in WT mice versus Sarm1-KO mice, which are resistant to axonal degeneration due 
to loss of SARM1, an enzyme that controls axon death via NAD+ depletion 37. We found that at 
14 days following transection, PNS macrophages became ameboid and were highly phagocytic 
in WT nerves, whereas in Sarm1KO nerves macrophages remained elongated and non-
phagocytic (Fig. 31a). Indeed, there appeared to be no significant myelin breakdown in 
Sarm1KO mice while WT mice exhibited a high degree of breakdown (Fig. 31b). These results 
suggest that phagocytic activation in PNS macrophages is tightly controlled by axonal 
destruction. 
 
4.2.5 Polarization of lipid metabolism and pro-inflammatory genes in PNS 
macrophages 
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To examine gene expression in PNS macrophages after injury, we performed single cell 
RNA-sequencing on injured nerves 4 days after nerve crush (Fig. 32). Focusing only on 
macrophages, we observed a small population (cluster 2) that was highly enriched for genes 
related to lipid metabolism (Fabp5, Pld3, Gpnmb, Plin2, and Trem2). Since our lab has recently 
identified several of these lipid-related markers to be upregulated in “foamy” macrophages in 
atherosclerotic plaques 38, we reasoned that cluster 2 macrophages may be similarly lipid-laden 
foam cells. To confirm this, we performed flow cytometry on nerves 3 weeks after injury and 
probed for lipid content using BODIPY dye. BODIPY+ macrophages were identified in the 
injured nerve and exhibited increased side scatter, indicating increased cellular granularity (Fig. 
33a,b).   
We also observed the expression of pro-inflammatory cytokines Cxcl2 and Il1b, which 
were distinct from the highly specific foamy macrophages in cluster 2, but were instead part of 
the Ccr2+ population. Indeed, macrophages in cluster 2 were notably negative for Ccr2 
expression, suggesting that they are either resident macrophages or recruited cells that have lost 
Ccr2 expression. Interestingly, there was some overlap in Abca1, Plin2 and Trem2 with the 
Ccr2+ pro-inflammatory subset. Thus, while there is a distinct separation between non-
inflammatory Ccr2- foamy macrophages and Ccr2+ inflammatory monocytes/macrophages, 
there seems to be a shared region where some lipid-associated genes are co-expressed with pro-
inflammatory markers, perhaps reflecting a gradient of macrophage differentiation (Fig. 32).  
Given the unique activation response observed after nerve injury, we were interested to 
see how lipid-associated and pro-inflammatory genes of interest are expressed in other 
conditions of nerve dysregulation. We thus combined our SC-RNA-sequencing data from sciatic 
nerve crush injury, TSC2-SCKO, and steady state nerves to generate a combined single cell atlas 
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containing macrophages and other immune cells from the three conditions (Fig. 34a,b). 
Interestingly, macrophages from both crush injury and TSC2-SCKO showed a similar pattern of 
separation between cells expressing the lipid-associated gene Trem2 and cells expressing Ccr2 
(Fig. 34c). Moreover, macrophages enriched for Trem2 in injury also uniquely expressed the pro-
regenerative gene Arg1 and microglia activation-associated gene Spp1 (Fig. 34c). These results 
suggest that macrophages in both crush injury and TSC2-SCKO are uniquely polarized with a 
lipid-associated Ccr2- subset representing a pro-regenerative state that is distinct from pro-
inflammatory Ccr2+ monocytes/macrophages.  
 
4.2.6 Targeting lipid metabolism in PNS macrophages may influence nerve 
regeneration 
    We next wanted to assess whether targeting lipid-associated genes in nerve macrophages 
affects nerve regeneration. Since APOE has been linked to foam cells in atherosclerosis via its 
role in reverse cholesterol transport 39, we sought to examine injury response in APOE-KO mice 
using an inverted screen test, which measures the ability of mice to hang onto an inverted screen. 
As expected, all mice lost their ability to hang onto the screen during the first and second week 
following injury (Fig. 35a). However, by the third week, two mice (1 in each genotype) regained 
performance (Fig. 35a). Interestingly, improvements in performance were correlated with 
macrophage numbers, including BODIPY+ foam cells, regardless of genotype (Fig. 35b). While 
the number of mice was insufficient to determine significance, Apoe genotype did not appear to 
affect performance on the inverted screen test after injury. 
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    Another gene that is functionally associated with APOE and also has been shown to 
regulate lipid handling is TREM2 40,41. Interestingly, the ability for TREM2 to regulate microglia 
activation responses in neurodegeneration also seems to be important for the regulation of 
cholesterol metabolism after myelin phagocytosis 41. Indeed, it appears that TREM2 signaling 
contributes to cholesterol efflux, which is essential for microglia metabolism after phagocytic 
challenge 41,42. To assess recovery after sciatic nerve crush in TREM2-KO versus WT mice, we 
measured the sciatic functional index (SFI) in both groups up to 3 weeks after injury (Fig 36a). 
While there appeared to be a slight trend of reduced SFI in TREM2-KO mice, no significant 
difference in regeneration was found.  
    To further assess both TREM2-KO and APOE-KO mice with an additional screening 
method, we performed nerve conductance velocity (NCV) testing after sciatic nerve crush 
injuries (Fig. 36b). We again saw an apparent trend in reduced NCV in TREM2-KO mice early 
after injury, but observed no significant difference in regeneration between the groups over time 
(Fig 36b). These results suggest that APOE and TREM2 are not critical for the recovery of 
peripheral nerve function after injury in adult mice.  
    Although we did not observe any difference in regeneration with our genetic models for 
disrupting lipid metabolism, we reasoned that environmental factors could perhaps mediate 
regeneration through foam cells. Indeed, Berghoff and colleagues have shown that dietary 
cholesterol can improve repair of demyelinated brain lesions by glial cells in adult mice 43. This 
prompted us to test whether increasing dietary cholesterol by high fat diet (HFD) feeding could 
affect the regeneration response after injury. We started HFD two weeks prior to injury and 
maintained it throughout the course of NCV testing. Remarkably, HFD-fed WT mice exhibited a 
significant increase in NCV, reaching nearly normal levels of nerve conductance by 2 weeks 
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after injury (Fig. 36c). HFD-fed TREM2-KO mice also showed improved NCV compared to 
chow-fed controls (Fig. 36c). Since TREM2 is highly specific to macrophages, this suggests a 
partial dependence on macrophages for HFD-enhanced regeneration after injury. To examine 
whether HFD enhances regeneration when macrophage numbers are significantly reduced, we 
performed nerve crush in CCR2-KO mice, in which monocyte recruitment is diminished, and 
administered HFD directly after injury. Indeed, CCR2-KO mice also showed a significant 
improvement in NCV after HFD feeding (Fig 36d). Therefore, we suspect that dietary lipids 
facilitate regeneration through both macrophages and peripheral glia, which likely possess 
compensatory roles for restoring nerve signaling after injury.  
 
4.3 Discussion 
Here we find strong evidence that the nerve environment shapes PNS macrophage 
signatures. Specifically, we show that Schwann cells, the major myelinating cell type in the PNS, 
have an important influence on nerve macrophages. While it is apparent that macrophages 
expand significantly in TSC2-SCKO mice, the mechanism by which this occurs remains a 
mystery. One interesting observation is the expression of genes associated with development, 
cell cycle dysregulation, and growth arrest, which raises questions about the differentiation state 
of PNS macrophages in this model. If PNS macrophages exist in a state that is not fully 
differentiated in this model, their expansion could perhaps be a remnant from earlier 
developmental processes. Further experiments are needed to determine whether PNS 
macrophage expansion occurs during development and whether immature PNS macrophages 
express similar genes as TSC2-SCKO macrophages. 
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Future experiments should also examine signaling pathways between Schwann cell 
precursors and PNS macrophages in TSC2-SCKO mice. Could macrophage numbers be “tuned” 
according to Schwann cell precursor density, which is increased by at least 10-fold in TSC2-
SCKO 25? Indeed, a similar effect has been reported between macrophages and fibroblasts, with 
in vivo experiments showing that cell cultures containing only fibroblasts and macrophages will 
reach a stable 1:1 ratio by 15 days regardless of starting ratio 44. This two-cell circuit effect can 
be attributed to local growth factors, including PDGF and CSF1 that are secreted by 
macrophages and fibroblasts, respectively, to support the survival of the other 44. Interestingly, 
endoneurial fibroblasts are known to arise from the neural crest and share a precursor state with 
Schwann cells. Future experiments should examine potential signaling pathways between 
Schwann cell precursor populations and macrophages in TSC2-SCKO mice. Findings from such 
studies may have clinical implications for diseases such as glioma, which similarly exhibit an 
increase in glial progenitor-like cells 45. It will be interesting to consider if enhancing the 
activation of PNS macrophages, perhaps by Sall1 or Tgfbr knockdown, increases phagocytosis of 
expanded glia in these models. 
The elevation of microglial genes, including Sall1, and reduction of PNS macrophage 
genes in TSC2-SCKO mice further demonstrates that there are underlying similarities between 
CNS microglia and PNS macrophages. At the molecular level, the shift in microglial signatures 
may be explained by increased TGF-β signaling. Indeed, the >2-fold increase in whole nerve 
expression of Tgfb1 and Tgfb2, and the parallel increase in Tgfbr1 in sciatic nerve macrophages 
in TSC2-SCKO mice strongly supports the role of TGF-β in this model. In a separate project 
involving single nuclei sequencing in peripheral nerves, we observe that many PNS cell types, 
including endothelial cells, stromal cells, macrophages, and Schwann cells, express Tgfb1 during 
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steady state. Future studies should investigate which cells are producing TGF-β in TSC2-SCKO 
and whether TGF-β also has a proliferative effect on PNS macrophages. 
While we hypothesized that microglial activation genes would be reduced in vagal nerve 
macrophages due to the relatively reduced myelination of vagal nerves compared to sciatic 
nerves 33, we were surprised to see instead the significant upregulation of interferon-related and 
antigen presentation genes in vagal nerve macrophages. We previously missed these genes when 
we included fascial nerves in our analysis, since fascial nerve macrophages also expressed 
elevated immune defense genes 34. It is interesting to consider whether the upregulation of 
immune defense genes is due to the presence of microbiota in the innervation targets of vagal 
and fascial nerves, which innervate the respiratory/digestive tract and skin, respectively. This 
raises the possibility that downstream molecules may travel up the nerve, perhaps via fluid 
drainage channels. Since interferon-related genes are also apparently enriched in grey matter 
microglia 7, it is possible that there is indeed a link between macrophage signatures and 
myelination. It is also interesting that vagal nerve macrophages expressed higher homeostatic 
microglia genes. This could be attributed to the fact that the vagus nerve is a cranial nerve that is 
directly connects to the brain. The vagus is also unique in that it is primarily comprised of 
parasympathetic fibers, which are not present in the sciatic, and may provide unique signals 33. 
Whether microglial homeostatic or activation-associated genes are associated with a proximal to 
distal or distal to proximal gradient in vagal nerves is also interesting to consider.  
Since herpesvirus infection of the nervous system is a common occurrence with 
potentially dangerous complications 13, it is important to examine the role of PNS macrophages 
in the context of HSV infection. While we infected mice by an intravaginal route, we were 
surprised to see a robust effect on macrophage numbers in the sciatic nerve. One explanation 
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could be that infection of shared DRG neurons innervating both the vagina and sciatic nerve 
leads to anterograde travel of HSV-1 down to the sciatic. Indeed, we saw apparent viral particles 
being engulfed by phagocytic macrophages in the sciatic and even further down near the distal 
portion. If true, this could have novel implications for chronic pain conditions such as sciatica. 
Additionally, there may be implications for CNS neurodegenerative diseases. Given the ability of 
HSV to translocate into the CNS in both mouse models and in humans, there has been a 
longstanding interest in HSV infection and neurodegenerative diseases such as AD 13-15. 
Remarkably, mice expressing humanized APOE4, which encodes the APOE isoform most highly 
associated with Alzheimer’s disease risk, have higher rates of CNS translocation 46. Future work 
should examine the role of APOE and PNS macrophages in herpesvirus infection, including their 
implications for virus-induced nerve pain and HSV translocation to the CNS.  
Our observations in nerve injury indicate that CD68+ foamy PNS macrophages represent 
a sensitive marker for neurodegeneration that specifically localizes to areas of axonal 
breakdown. Others have also shown CD68 staining to be associated with activated microglia in 
the brain 47. Spatial studies in both CNS and PNS may therefore utilize CD68 as a marker to 
detect regions of degeneration. Since we also found a high degree of specificity between cells 
expressing high levels of Cd68 and cells expressing high levels of foam cell genes, including 
Trem2, Fabp5, and Gpnmb, we speculate that macrophage activation beginning with early 
myelin engulfment leads to downstream lipid metabolic processes and eventual resolution of 
inflammatory responses. Indeed, our single cell RNA-seq experiments show that as early as 4 
days after crush, foam cells express Arg1, which is associated with immunosuppression in 
macrophages 48. Future experiments should examine macrophage signatures further out after 
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injury to determine whether pro-inflammatory cells transition into anti-inflammatory cells and 
whether this occurs through lipid uptake and efflux. 
The pairing of lipid efflux with inflammatory resolution in PNS macrophages warrants 
further exploration. Indeed, evidence from studies in atherosclerosis and CNS demyelination 
suggests that lipid efflux may be critical for mediating disease outcomes 49,50. Lipid efflux has 
also been suggested as a mechanism to transport lipids to directly support remyelination, 
particularly in early stages following CNS injury. In these studies, Berghoff and colleagues show 
that while microglia were important contributors to early remyelination in CNS demyelinating 
conditions, oligodendrocytes and their precursors were more important for remyelination in later 
stages 24. This could perhaps explain why we did not observe an effect for TREM2 or APOE in 
regeneration, as Schwann cells may be able to facilitate their own remyelination. Future 
experiments should examine these and other genetic regulators in aged mice, which show deficits 
in regeneration. Studies that target lipid metabolism in PNS macrophages, whether through diet 
or other methods,  may reveal new strategies for remyelination and reducing inflammation in 
peripheral neuropathies.  
 
4.4 Materials and methods 
Experimental animals 
    Mouse care and experiments were performed in accordance with protocols approved by 
the Institutional Animal Care and Use Committee at Washington University in St. Louis under 
the protocols 20170154 and 20170030. Mice were kept on a 12 h light–dark cycle and received 
food and water ad libitum. The following strains were used: C57/B6 CD45.1 (stock number 
002014), CX3CR1GFP/+(Cx3cr1tm1Litt/LittJ; stock number 008451), and RosaLsl-Tomato (stock 
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number 007905) mice were purchased from Jackson Laboratory (JAX) and bred at Washington 
University. APOE-KO, TREM2-KO mice were previously described and generated at 
Washington University, and Sall1-GFPmice were kindly provided by M. Rauchman. 
 
Sciatic nerve injuries  
For all injuries, mice were anesthetized with Avertin. Then the left sciatic nerve was 
exposed and crushed for 30 seconds or transected above the branching point but below the sciatic 
notch. Mice were then given subcutaneous analgesic and monitored for three days.  
 
Nerve conductance velocity testing 
NCV was done using Viking machine. Mice were anesthetized with isoflourane and 
electrodes were placed in the sciatic notch and footpad or in the ankle and footpad. Velocities 
and latency were determined with the software. 
 
High Fat diet 
HFD (42% fat Envigo TD.88137) was given prior to injuries for 2 weeks. Mice were 
weighed before the administration of HFD and in 2 week increments after HFD.  
 
Immunohistochemistry 
For whole-mount imaging, samples were harvested and immediately stored in 4% 
paraformaldehyde (PFA) containing 40% sucrose overnight. Samples were then washed in 
phosphate-buffered saline (PBS), blocked, stained, and imaged. For frozen sections, samples 
were collected, stored in PFA/sucrose, and embedded into optimal cutting 
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temperature compound. Fifteen-micrometer cuts were made for SNs. Sections were then blocked 
in 1% bovine serum albumin, stained, and imaged. Antibodies to the following proteins were 
used: CSF1R (R&D Systems, accession number P09581), MHCII (IA/IE clone M5/114.15.2), 
CD68, GFAP, PDPN, and LYVE1 (ab14917). 
 
Preparation of single-cell suspensions 
For blood, mice were bled from the cheek immediately before killing and cells were 
prepared as previously described. For nerves and all other tissues, mice were killed and perfused 
with PBS. Nerves were collected and kept on ice until dissociation. Cells were then incubated 
with gentle shaking for 20 min in digestion media containing collagenase IV, hyaluronidase, and 
DNAse. Cells were then washed and filtered through 70 µm cell strainers. For brain and spinal 
cord, myelin was removed using a 40/80% Percoll gradient. 
 
Flow cytometry 
Single-cell suspensions were stained at 4 °C. Dead cells were excluded by propidium 
idodide (PI). Antibodies to the following proteins were used: B220 (clone RA3-6B2), CCR2 
(clone SA203G11), CD3e (clone 145-2C11), CD4 (clone RM4-5), CD8 (clone 53-6.7), CD11b 
(clone M1/70), CD16 (clone 2.4G2), CD45 (clone 30-F11), CD64 (clone X54-5/7.1), CD115 
(clone AFS98), GR1 (clone 1A8), and Ly6C (clone HK1.4). Cells were analyzed on a LSRII 




    For bulk RNA-seq, cells from 6-week-old male mice were double sorted on a FACSAria 
II (Becton Dickinson) for a final count of 1000 cells into lysis buffer according to the ImmGen 
Consortium standard operating protocol. Tissues were collected into culture medium on ice and 
subsequently digested with collagenase IV, hyaluronidase, and DNAse. Following digestion, 
samples were washed and kept on ice until sorting. The sort was repeated so that all 
macrophages were sorted twice, with a minimum of 1000 cells recovered. During the second 
round, cells were sorted directly into 5 µl TCL buffer (Qiagen) containing 5% beta-
mercaptoethanol. Samples were kept at −80 °C until further processing. For sorting in 
preparation of the Flt3-Cre LSL-YFP single-cell Seq experiments, SNs from 19 male mice aged 
10–12 weeks were combined and CD64+ CD45int macrophages were sorted individually into 
YFP+ and YFP− groups, yielding 18,000 and 5,000 cells, respectively. Both groups were 
immediately run on the 10× Genomics Chromium Controller according to the manufacturer’s 
protocol. 
 
RNA-seq and data analyses 
    Library preparation, RNA-seq, data generation and quality-control was conducted by the 
ImmGen Consortium according to the consortium’s standard protocols 
(https://www.immgen.org/Protocols/ImmGenULI_RNAseq_methods.pdf). In short, the reads 
were aligned to the mouse genome GRCm38/mm10 primary assembly and gene annotation 
vM16 using STAR 2.5.4a. The raw counts were generated by using featureCounts 
(http://subread.sourceforge.net/). Normalization was performed using the DESeq2 package from 
Bioconductor. Differential gene expression analysis was performed using edgeR 3.20.9 in a 
pairwise manner among all conditions, and a total of 12,240 DEGs were defined with a p-
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value ≤ 0.001 and ≥4-fold difference. To construct the correlation plot, Euclidean distance among 
samples were calculated based on the differential expression matrix and clustering was 
performed using the ward.D2 algorithm in R. CNS/PNS shared, PNS-specific, and CNS-specific 
genes were determined by subclustering the DEGs based on the expression pattern with a 
refined k-mean clustering using R followed by manual curations. For neuronal microenvironment 
analysis, only the transcriptome profile of macrophages and microglia from PNS and CNS were 
used and analyzed through the same pipeline as mentioned above. 
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Figure 25. PNS macrophage expansion in TSC2-SCKO mice with dysmyelinated nerves. a. light 
microscopy of sciatic nerves from WT control and TSC2-SCKO mice at age P28 reveals dysmyelinated 
nerves in the mutant. b. Nerve conductance velocity (NCV) plot showing representative signals from WT 
an TSC2-SCKO mutant sciatic nerves. c. Confocal imaging and flow cytometric quantification of GFP+ 
macrophages in sciatic nerves (top) and brains (bottom) in CX3CR1-GFP/+ control mice and CX3CR1-









Figure 26. Gene expression analysis of TSC2-SCKO mice reveals upregulation of microglial genes 
and downregulation of PNS macrophage genes. a. Fold change in previously identified PNS 
macrophage-enriched genes. b. Differential expression of genes related to neuronal connectivity/support, 
gli/hedgehog, activation/immune response, and endosomal/retromer functions in WT and TSC2-SCKO 
macrophages. c. Upregulation of homeostatic microglia (M0) genes in PNS macrophages from TSC2-
SCKO (left) and upregulation of Tgfb1 and Tgfb2 expression in whole sciatic nerves of TSC2-SCKO 
mice. d. Correlation between Sall1 expression and Tgfbr1 expression in sciatic nerve macrophages and 





Figure 27. Single cell analysis of PNS macrophage heterogeneity in TSC2-SCKO. a. Clustering of 
CD45+ immune cells from TSC2-SCKO sciatic nerves. b. Expression of microglial genes in TSC2-SCKO 





Figure 28. Differential expression of steady state genes associated with myelinated and 
unmyelinated nerves. Genes enriched in macrophages from sciatic nerves (left) containing 
predominantly myelinated axons, and vagal nerves (right) containing predominantly unmyelinated axons. 
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Table 3. Gene ontology analysis of genes enriched in sciatic nerve macrophages. 
 
GO term Description P-value FDR q-value Enrichment N, B, (n, b) 
GO:0022029 telencephalon cell migration 1.56E-4 1E0 14.54 (12726,35,100,4) 
GO:0021885 forebrain cell migration 1.74E-4 1E0 14.14 (12726,36,100,4) 
GO:0001525 angiogenesis 2E-4 9.51E-1 4.99 (12726,204,100,8) 
GO:0060045 positive regulation of cardiac 
muscle cell proliferation 
2.96E-4 1E0 22.46 (12726,17,100,3) 
GO:0071715 icosanoid transport 3.53E-4 1E0 21.21 (12726,18,100,3) 
GO:1901571 fatty acid derivative transport 3.53E-4 8.37E-1 21.21 (12726,18,100,3) 
GO:0098609 cell-cell adhesion 5.8E-4 1E0 4.26 (12726,239,100,8) 





Table 4. Gene ontology analysis of genes enriched in vagal nerve macrophages. 
 
GO term Description P-value FDR q-value Enrichment N, B, (n, b) 
GO:0060700 regulation of ribonuclease 
activity 
1.14E-9 1.63E-5 91.82 (12726,11,63,5) 
GO:0035458 cellular response to 
interferon-beta 
2.81E-8 2E-4 31.89 (12726,38,63,6) 
GO:0001912 positive regulation of 
leukocyte mediated 
cytotoxicity 
1.2E-7 4.29E-4 25.25 (12726,48,63,6) 
GO:0002376 immune system process 1.22E-7 2.91E-4 3.56 
(12726,1190,63,21) 
GO:0043207 response to external biotic 
stimulus 
1.8E-7 3.2E-4 5.00 (12726,606,63,15) 
GO:0051607 defense response to virus 4.8E-7 6.22E-4 11.30 (12726,143,63,8) 
GO:0050792 regulation of viral process 2.03E-6 2.07E-3 9.34 (12726,173,63,8) 
GO:0043903 regulation of symbiosis, 
encompassing mutualism 
through parasitism 
3.49E-6 2.76E-3 8.69 (12726,186,63,8) 
GO:0001916 positive regulation of T cell 
mediated cytotoxicity 
4.5E-6 3.21E-3 35.13 (12726,23,63,4) 
GO:0045071 negative regulation of viral 
genome replication 
4.52E-6 3.06E-3 20.20 (12726,50,63,5) 
GO:0048525 negative regulation of viral 
process 
4.87E-6 3.15E-3 13.62 (12726,89,63,6) 
GO:0098542 defense response to other 
organism 
2.06E-5 1.13E-2 5.85 (12726,311,63,9) 
GO:0002486 antigen processing and 
presentation of endogenous 
peptide antigen via MHC 
class I via ER pathway, TAP-
independent 













Figure 29. PNS macrophage response to HSV infection. a. Flow cytometric analysis of sciatic nerve 
macrophages in naïve mice and mice infected intravaginally with HSV-1 and HSV-2 at days 1 and 5 post 
infection. b. Confocal imaging of HSV-2 infected sciatic nerve (day 2) with MHC-II+ macrophages and 
PDPN+ fibroblasts. c. Confocal imaging of proximal and distal sciatic nerves in CX3CR1CreER 





Figure 30. PNS macrophage activation and monocyte recruitment following nerve crush injury. a-d. 
Confocal imaging of sciatic nerves after crush injury showing proximal region (left), crush site (middle), 
and distal region of nerves (right). a. Resident (red) and recruited (blue) macrophages 3 days post crush. 
b. Recruited monocytes in CSF1R mAb-depleted mice 3 days post crush with lectin-stained blood 
vasculature. c. Resident (red) and recruited (blue) macrophages 7 days post crush with GFAP+ reactive 





Figure 31. Phagocytic activity in PNS macrophages after nerve transection requires nerve 
breakdown. a,b. Confocal imaging of distal portion of transected sciatic nerves in WT and SARM1-KO 
mice 7 days after transection. a. CD68+ phagocytic macrophages (red) and BODIPY+ Schwann cells 
(green) in WT (left) and SARM1-KO (right) transected nerves. B. Myelin integrity revealed by BODIPY 







Figure 32. Single cell analysis of macrophage heterogeneity after crush injury. (Top) Subclustering 
in Csf1r+ macrophages isolated from CD45+ immune cells 4 days after injury. (Bottom left) Distribution 
of foamy macrophage-associated genes (from Kim. et al 2019). (Bottom right) Distribution of pro-









Figure 33. Identification of lipid-laden macrophages after sciatic nerve crush injury. a. Flow 
cytometric characterization of BODIPY+ macrophages 21 days after crush injury. b. Confocal imaging of 

















Figure 34. Combined peripheral nerve immune atlas reveals shared patterns of macrophage 
polarization. a. Clustering analysis of single cell RNA-seq data combined from injury (day 4 injury), 
TSC2-SCKO, and steady state CD45+ cells. b. Subclustering analysis of combined populations. Circles 
represent macrophages from injury (red) and TSC2-SCKO (blue). c. Distribution of differentially-








Figure 35. Macrophage numbers correlate with functional recovery after sciatic nerve crush injury. 
a. Inverted screen test scores across time in WT and APOE-KO mice after crush injury identifies mice 
with high and low functional recovery by 3 weeks after injury. b. Flow cytometric analysis of mice with 







Figure 36. Functional recovery is enhanced after high fat diet feeding. a. Sciatic functional index 
(SFI) scores in WT and TREM2-KO mice after nerve crush injury. b. Nerve conduction velocity (NCV) 
in WT, TREM2-KO and APOE-KO mice after sciatic crush injury. c. NCV scores in WT and TREM2-
KO mice fed normal chow versus high fat diet (HFD) 2 weeks prior to injury. d. NCV scores in WT and 
CCR2-KO mice fed normal chow versus high fat diet (HFD) starting on the day of injury. 
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5. Conclusion and Future Directions: 
As unique cells that maintain host defense and tissue homeostasis, macrophages have 
been a centerpiece in pathology and immunology research. While advances in their study have 
revealed diverse functions with important implications for regulating disease outcomes, the 
population of macrophages in the peripheral nervous system (PNS) has been largely overlooked. 
In this dissertation, I characterized PNS macrophages by revealing their transcriptional identity 
and ontogeny, as well as their responsiveness to disturbances in the nerve environment. I provide 
compelling evidence that PNS macrophages are inherently microglia-like yet possess features 
unique to peripheral nerves. These findings open up new areas of research and provide a broader 
perspective for examining neural resident macrophages.   
I found that PNS macrophages are self-maintaining resident cells that express genes 
previously thought to be specific to homeostatic microglia 1. In light of recent studies that 
demonstrate the inducible expression of microglial genes in naïve cells transplanted into the 
brain 2,3, it thus appears that shared signals from the central and peripheral nerve environments 
endow neural resident macrophages with common transcriptional features. Indeed, TGF-β 
signaling and its promotion of microglial genes, including the transcription factor SALL1, is a 
prime candidate 4,5. Future work should examine what other signals are acting on PNS 
macrophages to elicit expression of microglial genes, and whether boosting or eliminating these 
signals has an effect on PNS macrophage functions. 
PNS macrophages also express unique genes that reflect their specific functions in 
peripheral nerves 1. An interesting question for future research will be why PNS macrophages 
express these genes, and why many of these transcripts are associated with microglial activation. 
Since microglia activation signatures have been strongly attributed to phagocytosis of neuronal 
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components, one question is do PNS macrophages constitutively engulf more myelin than CNS 
microglia? Although it has been shown that myelinating SCs do not actively turn over in mice 
during adulthood 6, the PNS is more exposed to a multitude of stressors in the real world. Could 
these physical factors induce myelin “shedding” that requires uptake and recycling by 
macrophages? Future experiments may examine the range of nerve “damage” needed to induce 
phagocytic activity in PNS macrophages across various challenges and determine whether 
consistent challenge affects subsequent regenerative capacity in the same animals.  
It will also be important to understand the role of PNS macrophages in normal nerve 
remodeling throughout adulthood. From our transcriptional profiling experiments, it is apparent 
that in 6 week-old juvenile mice there is active expression of genes involved in angiogenesis, 
axon guidance, and extracellular matrix remodeling 1. Future studies should investigate the 
degree of PNS macrophage involvement in establishing and maintaining PNS circuitry. For 
example, do PNS macrophages facilitate motor skill acquisition by helping to strengthen specific 
circuits? If so, do they act on neuronal synapses by pruning the neuromuscular junction, or on 
Schwann cells to guide appropriate myelin remodeling, or a combination of both? These studies 
may have exciting implications for macrophages in neuroplasticity across lifespan. 
Another important area for future research is the role of PNS macrophages in nerve 
infections, including bacterial, fungal, and viral infections. While it remains unclear how PNS 
macrophages provide host protection, their significant expression of MHC-II and interferon-
induced genes suggest that they are highly capable of responding to infections. I showed that 
macrophage numbers in sciatic nerves are significantly elevated following intravaginal HSV 
infection. Furthermore, phagocytic macrophages in the sciatic nerve seemed to contain virus 
particles, suggesting that viral engulfment is a common mechanism in macrophages for 
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controlling HSV infection 7. Since HSV travels bidirectionally in nerves 8, it is conceivable that 
retrograde infection of DRGs from the intravaginal route was followed by anterograde infection 
of sciatic nerves. This mechanism could also explain how HSV-1 spreads to enteric neurons after 
intravaginal infection, a process that requires TRPV1+ nociceptors 9. Future experiments in this 
model should clarify whether virus needs to be present in the sciatic nerve for macrophages to 
expand. These studies may reveal new insights about virally-induced neuroinflammation and its 
potential link to neuropathic pain. Broader studies are also needed to examine whether PNS 
macrophages affect translocation of neurotropic viruses from peripheral nerves to the CNS.  
While the exact origins of PNS macrophages was unknown up to this point, I have shown 
in mice that they are embryonic- and HSC-derived cells that fully populate the PNS at birth and 
maintain steady numbers throughout the course of life 1. Given their origin, which can be traced 
to embryonic and early hematopoietic sources, PNS macrophages likely play important roles for 
PNS development and maturation. Future studies should characterize PNS macrophages 
throughout development and determine what roles they may play in nerve growth and 
maturation. Do they provide signals for Schwann cells, endoneurial fibroblasts, or endothelial 
cells to guide nerve development? How do their numbers change across the developmental 
process and what transcriptional signatures do they express during development? These studies 
will serve to improve our foundational understanding of PNS macrophages.   
Future studies should also examine more closely the role of PNS macrophages in nerve 
injury. While it has been shown that the majority of PNS macrophages after injury are monocyte-
derived 10, it is unclear if resident and recruited macrophages play specific roles. It is interesting 
to note that after CNS injury, monocytes perform functions that are important for reducing 
adverse outcomes 11. For instance, there is evidence that recruited monocytes are more 
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phagocytic, have unique scar-remodeling capabilities, and have a greater capacity for regulating 
pro- and anti-inflammatory mediators 12-14. In the PNS, Boissonnas and colleagues show that 
injury preferentially induces myelin stripping by recruited macrophages, whereas resident 
macrophages are more associated with axonal regrowth 15. Our own observations in nerve injury 
indicate that Ccr2+ macrophages express pro-inflammatory cytokines in the early stages 
following injury. Future studies in peripheral nerve injury should track inflammation and its 
resolution over time in peripheral nerve macrophages.  
I also found that a subset of Ccr2- PNS macrophages expresses lipid handling genes 
reminiscent of foamy macrophages from atherosclerotic lesions. This raises the question of why 
macrophages utilize lipids after nerve injury. One explanation could be that fatty acid oxidation 
fuels PNS macrophages to perform their known repair programs.  It has been shown that in heart 
repair after ischemic injury, macrophages utilize fatty acid derived from engulfment of apoptotic 
cells as a fuel source for shifting towards an anti-inflammatory tissue repair phenotype 16. 
Indeed, inflammation resolution after nerve injury has also been associated with IL-10 
production in macrophages 17, and our own data further shows that foamy macrophages after 
injury specifically express Arg1, which has been attributed to immunosuppression. Furthermore, 
PNS macrophages may use fatty acids in cholesterol efflux, which has also been strongly linked 
with inflammatory resolution 18,19. Studies that further characterize lipid metabolism in PNS 
macrophages after injury may reveal targets for improving inflammatory resolution after injury.  
Lastly, I show that high fat diet (HFD) feeding improves regeneration after nerve injury. 
Although it remains unclear whether these benefits work primarily through macrophages or other 
cells, the attenuation of diet-enhanced nerve recovery in TREM2-KO mice suggests that the 
phenotype is at least partially dependent on macrophages. Future studies may determine the 
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extent of macrophage involvement and investigate whether lipid supplementation reduces 
inflammation, improves remyelination, or both. Furthermore, research is needed to determine 
optimal timing, dosage, and lipid specificity. These studies may have implications for 
personalized treatment of nerve injuries and the prevention of adverse outcomes such as injury-
associated chronic pain. 
Up to now, the brain and spinal cord of the CNS are the only tissues thought to possess 
microglia. Our comparison of resident macrophages from both the PNS and CNS challenges this 
notion and supports the idea that some microglial features and transcriptional programs are 
shared in macrophages across the nervous system, whereas critical features remain distinct. 
These findings provide new implications for the health and preservation of the PNS and open the 
door to unexplored topics in neuroimmune research.   
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